Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
SOX8		ENSG00000005513	SRY-box 8	P57073	16	981808-986979	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 64.9	Cell type enriched	Detected in some	22	Muller glia cells: 120.0	Cancer enriched	Detected in many	6	glioma: 46.9	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1	Lineage enriched	Detected in single	23	T-cells: 2.2	Cell line enriched	Detected in some	5	RH-30: 51.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041640, HPA058665			Enhanced	Nucleoplasm		No				Nucleoplasm		HPA041640: AB_10964357, HPA058665: AB_2683792	unprognostic (1.40e-2)	unprognostic (2.56e-3)	unprognostic (1.59e-1)	unprognostic (3.10e-2)	unprognostic (4.58e-2)	unprognostic (7.16e-3)	unprognostic (6.05e-3)	unprognostic (3.01e-2)	unprognostic (2.53e-1)	unprognostic (1.16e-1)	unprognostic (4.53e-3)	unprognostic (4.46e-2)	unprognostic (1.20e-3)	unprognostic (8.50e-2)	unprognostic (6.18e-2)	unprognostic (5.47e-1)	unprognostic (9.09e-2)	1.6	1.5	18.4	1.8	25.1	1	2.5	3.2	64.9	1.2	1.4	20.9	0	1.1	1.1	1.1	1.2	1.1	1.5	1.8	22.6	14.5	1	1	1	2.7	26.5	5.4	1	1.5	1	0.1	1.4	12	1.3	1.5	0.9	8.6	1.4	1.3	1.3	1.2	1.2	27.1	1.8	1.7	1.9	30.4	0	1.1	0	3.1	1.1	0.3	0	0	0	0	0	2.2	0.2	0	0.3	1	9.7	0	0	0	0	0	0	0	0.5	0	0	0.6	0	0	0.1	2.2	0	0	0	0.6	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0.1	0.1	0	0	0	0	1.5	0.7	0.1	0	51.7	1.9	0	0	0	0	0	0	1.7	0.1	0	0	0	0	0.3	0	0	0	0	0.4	0.1	0.1	3.8	0	0	0	0	0	0	0	0.5	0.1	0	0	2.2	1.1	0	0	0	0	0	0.2	18.4	25.1	3.2	11.8	22.6	14.5	26.5	5.4	12	30.4	0	0	0	0.4	0.3	1.4	1.1	0	0	0	0	0	0	0	0.4	0	1.1	0	0	0.2	0.1	2.1	1.4	0	0	0.1	0	0	1.3	0	0	3.1	0	1.7	1	0	120	0.1	0	1.8	0	5.3	0	0.8	0	4.3	0.9	0	0	0	0.1	Muller glia cells
GPM6B	M6B, MGC17150, MGC54284	ENSG00000046653	Glycoprotein M6B	Q13491	X	13771031-13938638	Predicted membrane proteins	Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 219.5	Cell type enriched	Detected in many	6	Muller glia cells: 1904.1	Group enriched	Detected in many	14	glioma: 192.5;melanoma: 41.0	Low region specificity	Detected in all			Cell type enriched	Detected in single	222	plasmacytoid DC: 33.4	Lineage enriched	Detected in single	240	dendritic cells: 33.4	Cell line enhanced	Detected in some		AF22: 42.8;AN3-CA: 42.4;ASC TERT1: 21.8;HSkMC: 32.1;SK-MEL-30: 42.1	Low region specificity	Detected in all							HPA002913	Approved											HPA002913: AB_2263553	unprognostic (1.56e-2)	unprognostic (3.42e-1)	unprognostic (1.83e-1)	unprognostic (3.70e-2)	unprognostic (8.55e-2)	unprognostic (2.75e-3)	unprognostic (2.12e-2)	unprognostic (1.92e-2)	unprognostic (4.27e-2)	prognostic favorable (2.67e-4)	unprognostic (1.79e-2)	unprognostic (4.78e-2)	unprognostic (2.38e-3)	unprognostic (8.34e-2)	unprognostic (2.12e-1)	unprognostic (1.04e-2)	unprognostic (2.00e-1)	4.6	5.5	68.4	3.9	55.1	2	12.4	24.1	219.5	10.2	5.7	68.7	1.1	3.6	4.3	6.7	6.4	4.2	3.9	5.9	62.6	33.1	4.5	2	6.7	2.6	68.9	47.3	3.1	2.9	1.9	2.6	2.1	44.1	9.9	4.9	3.2	7.4	16.9	2.1	7.1	4.3	3.8	109.4	7.2	3.3	3	64.8	0	3.5	0	2.3	3.3	2.7	0.1	33.4	0.1	0	0.1	0.1	0.2	0.1	0.1	42.8	42.4	12.1	21.8	0.1	0.2	1.9	0	0	0.1	0.1	0.2	0	0	0.1	0.3	2.1	0.2	0	0.1	7	0.1	2.8	0.1	0.4	0.1	0.2	32.1	0.2	0	0.5	0.1	0	0.8	0.1	1.9	0.4	0.1	0.9	0.1	13.4	0	0.7	0.5	3.8	6.5	0	0.1	2.1	1.2	0.2	1.2	42.1	12.3	0.2	0.9	0	0.2	0.3	0.1	0.5	0.1	0	0.1	0.4	0	3.5	0	0	0	0.1	0	0.1	0	0	0	0.1	0.1	0	0	0.1	0.1	0	33.4	0	0.2	68.4	55.1	24.1	43.1	62.6	33.1	68.9	47.3	44.1	64.8	0	3.2	20.4	22	29.3	74.8	1.1	0	13.4	5.7	21	82.5	3.8	0	3.2	0.4	6.3	3.8	0	3.3	2.8	24.2	20.1	4.6	0.4	1	25.4	1.2	16.5	1	1.5	22.5	1.8	339.1	2.8	2.6	1904.1	1.9	3.2	30.1	0.6	143.8	45.3	22.6	4.3	9.4	14.9	11.4	15.2	2.9	12.6	Muller glia cells
COL9A2	EDM2, MED	ENSG00000049089	Collagen type IX alpha 2 chain	Q14055	1	40300487-40317813	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Deafness, Disease mutation, Dwarfism, Stickler syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.3;pituitary gland: 32.1;retina: 40.8	Cell type enriched	Detected in many	9	Muller glia cells: 280.3	Cancer enhanced	Detected in all		prostate cancer: 68.2	Low region specificity	Detected in all			Group enriched	Detected in some	4	eosinophil: 6.4;myeloid DC: 2.7	Group enriched	Detected in many	6	dendritic cells: 2.7;granulocytes: 6.4	Cell line enhanced	Detected in some		HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3	Low region specificity	Detected in all							HPA056316, HPA075286	Supported		Approved	Nucleoplasm,Vesicles	Secreted to extracellular matrix					Vesicles	Nucleoplasm	HPA056316: AB_2683099, HPA075286: AB_2732288	unprognostic (1.42e-2)	unprognostic (3.54e-2)	unprognostic (8.94e-2)	prognostic unfavorable (5.13e-4)	unprognostic (4.46e-2)	unprognostic (1.83e-3)	unprognostic (2.06e-2)	unprognostic (9.00e-3)	unprognostic (1.73e-1)	unprognostic (1.26e-1)	unprognostic (1.56e-3)	unprognostic (2.26e-1)	unprognostic (1.16e-3)	unprognostic (4.28e-2)	unprognostic (2.56e-1)	unprognostic (5.89e-2)	unprognostic (1.71e-2)	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10	3.6	32	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.3	0.1	0.7	0.3	1	0.5	2.9	0	0	0.2	0.5	0.1	2.5	1.2	3.8	0.1	0	0.7	0	0	0.1	35.4	0.5	0.7	0.3	9.9	0.6	0.3	34.1	1.8	0	0	0	0.2	0	0.5	0	7.4	0	0.9	0.4	0.7	0.8	0	0.4	0.8	0	2.4	0	5.2	0.5	0.8	0	4.4	0.4	2.6	5.6	38.3	0	0	4.5	0	0.1	0.5	0	1.2	0.3	4.5	0.2	0	0.2	6.4	0	0.5	0	0.5	0.2	0	2.7	0.7	0.1	0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7	0	3.5	4.5	2.6	0.9	1.8	0.8	7.6	1.4	3.4	24.4	0	2.3	0	6.3	0	0	3.3	0	0.7	0.4	1.4	7.8	26.4	0	3.3	0	12.2	1.3	0.3	0.8	2	6.5	1.7	30.7	5.5	280.3	3.6	7	0	0.1	7.8	0	0.9	2.6	2.6	0.5	1.1	2.2	12.2	11.1	Muller glia cells
COL23A1	DKFZp434K0621	ENSG00000050767	Collagen type XXIII alpha 1 chain	Q86Y22	5	178237618-178590555	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		thyroid gland: 42.3	Cell type enriched	Detected in some	5	Muller glia cells: 56.2	Cancer enhanced	Detected in many		renal cancer: 41.3	Low region specificity	Detected in many			Cell type enriched	Detected in single	5	plasmacytoid DC: 3.1	Lineage enriched	Detected in single	5	dendritic cells: 3.1	Group enriched	Detected in some	4	K-562: 8.1;NB-4: 23.1;THP-1: 23.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA067824	Uncertain											HPA067824: AB_2685907	unprognostic (5.24e-2)	unprognostic (2.65e-1)	unprognostic (6.65e-2)	prognostic unfavorable (6.46e-5)	unprognostic (3.04e-1)	unprognostic (8.67e-3)	unprognostic (1.14e-1)	unprognostic (3.62e-1)	unprognostic (2.12e-1)	unprognostic (3.52e-2)	unprognostic (3.96e-2)	unprognostic (5.93e-3)	unprognostic (8.20e-2)	unprognostic (2.30e-1)	unprognostic (4.90e-2)	unprognostic (2.11e-3)	unprognostic (2.37e-1)	0.6	0.5	1.6	1.9	1.3	6.9	1.5	8.8	3.4	2.2	2.2	0.1	7.6	3.1	1.2	3.6	0.7	2	0.9	11.4	1.5	1	2.2	1.5	1.4	0.6	0.7	2.3	0.2	1.9	3	0.8	0.1	2.9	4.1	0.1	3.7	1.7	12.6	1.3	6.3	3.8	1.1	2.6	1.5	2.2	2.3	0.1	0.3	42.3	2.2	1.6	1	1.5	0	3.1	0	0.5	0.5	0	0.2	0	0	4	0.2	0.2	0	1.1	0	0	0	0	0	0	0.2	1	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	8.1	0.4	0	1	0	23.1	1.3	0	0	0	0	0.1	0	0	0.2	0.5	0	0	0	1.9	0	23	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0.2	0	0	0	0	0.5	0	3.1	0	0.2	1.6	1.3	8.8	3.4	1.5	1	0.7	2.3	2.9	0.1	0	0	0	2.5	1.9	0.7	10.9	0	0	0	0	0	0	0	0	0.3	2.1	0	0	0	0.2	1.3	0.4	0	0	0.5	0	0	1.8	1.6	0	0.3	0.9	0	0	0	56.2	0.1	0	2.5	0.5	2.5	6.5	4.7	1.1	2	4.1	0.1	0	0	0.1	Muller glia cells
GATB	PET112, PET112L	ENSG00000059691	Glutamyl-tRNA amidotransferase subunit B	O75879	4	151670504-151761023	Predicted intracellular proteins	Protein biosynthesis	Ligase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Muller glia cells: 317.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042610	Uncertain		Supported	Mitochondria						Mitochondria		HPA042610: AB_10797502	unprognostic (2.52e-1)	unprognostic (3.33e-1)	unprognostic (1.01e-3)	unprognostic (5.08e-2)	unprognostic (2.31e-1)	unprognostic (6.91e-2)	unprognostic (2.24e-1)	unprognostic (5.77e-2)	unprognostic (2.06e-1)	unprognostic (6.76e-2)	unprognostic (1.37e-1)	unprognostic (8.17e-2)	prognostic favorable (1.20e-10)	unprognostic (1.91e-1)	unprognostic (8.39e-2)	unprognostic (3.09e-2)	unprognostic (2.46e-1)	11.2	17	12.3	10.5	13.6	8.2	9.2	10.7	19.8	7.3	9.7	11.2	6.4	5.8	5.9	8.9	10.1	9.1	7	31.3	10.7	10.8	21.4	21.8	5.3	6.8	15.8	11.1	12.1	6.8	14.6	8.4	9.9	10.6	5.9	9.9	7.8	7.7	7.1	22.7	8.5	6.3	8.1	22.6	6.9	7.4	7.8	10.4	10.5	7.7	18.9	9.3	8	5.8	9.1	17	1.5	13.2	6.8	6.8	8.3	8.8	6.9	9.9	9.5	14.5	14	8.6	11.7	15.3	20.8	16.3	11.6	14.5	12	3.1	12.1	12.7	8.3	21.2	22.4	22.3	6.7	13	5.5	9.6	23.9	14.2	11.3	5.5	14.4	14.4	20	7	12	15.4	17.1	21.4	10.5	15.9	9.7	14.1	12.2	10.1	7.4	13	12	9.5	9.5	18.8	7.4	10.3	11.4	9.4	13	13.7	10	11	8.2	8.4	10.5	5.7	7.2	8	12.6	16.3	10	14.7	10	7.6	0.7	9.4	1.5	4	13.2	6.3	9.1	5.3	5.6	17	8.2	6.8	6.4	0.9	6.8	9.4	6.7	5.4	8.3	12.3	13.6	10.7	19.8	10.7	10.8	15.8	11.1	10.6	10.4	8.9	3.7	2.2	5.5	0	8.7	58.8	0	2.7	6.8	10.4	7.9	19.7	23.2	8.8	5.7	2.9	2.6	0	6.4	13.2	7.4	2.9	1.1	13.6	15.4	9.5	2.4	2.5	6.5	6	4.9	5.8	0	13.6	5.9	317.1	6.9	6.5	4.2	14.9	13.6	6.5	3.6	12.2	12	0	11.2	1.5	8.8	2.6	Muller glia cells
SLC1A3	EA6, EAAT1, GLAST	ENSG00000079215	Solute carrier family 1 member 3	P43003	5	36606355-36688334	Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Amino-acid transport, Symport, Transport		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	brain: 188.6	Cell type enriched	Detected in many	9	Muller glia cells: 579.8	Cancer enriched	Detected in all	21	glioma: 168.1	Low region specificity	Detected in all			Group enriched	Detected in some	12	classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4	Group enriched	Detected in many	39	dendritic cells: 3.4;monocytes: 4.3	Cell line enhanced	Detected in many		AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB002573, HPA037467, HPA037468	Enhanced	Supported	Approved	Nucleoli,Mitochondria						Mitochondria	Nucleoli	CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371	unprognostic (1.23e-1)	unprognostic (2.15e-2)	unprognostic (2.58e-3)	unprognostic (1.74e-2)	unprognostic (1.02e-1)	unprognostic (7.70e-2)	unprognostic (3.89e-3)	unprognostic (2.36e-1)	unprognostic (1.24e-1)	unprognostic (2.84e-2)	unprognostic (4.17e-3)	unprognostic (3.28e-1)	unprognostic (2.46e-1)	unprognostic (1.06e-1)	unprognostic (4.17e-2)	unprognostic (1.03e-1)	unprognostic (1.31e-2)	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0	2.1	2.8	2.3	7.2	5.4	5.9	12	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0	2.6	0.7	4.5	4.8	1.2	0	3.4	0	4.3	0	0	0.8	0.4	0.1	21.5	1.9	2.2	6	13.8	0	0	0.8	1.9	34.7	1.7	0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0	0.1	0	0.4	0.4	0.1	11.1	13	5.3	2.2	0.4	0	0.4	0	0.1	3.6	0	0	0.1	2.5	0	2.2	0	0.1	0	0	1.4	1.8	0	2.1	6.3	0.3	10.5	0	1	0	1.9	3.2	0	7.6	0	0	0	8.8	14.5	4.9	0	4.3	0	0	2.1	0	0	0	0	3.4	0	0	0	0	0	0.1	0.2	0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3	0.3	0.5	10.4	9.5	7.7	33.9	0	5.3	1.2	0	2	25.3	0	0.4	0.6	1.1	0	0	0	13.5	11.8	3.2	0	0.2	38.2	3.2	0	1.3	63.4	1.9	4	11	6.8	3.6	0	579.8	0.3	0	0	0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0	0	3.3	Muller glia cells
CDH7		ENSG00000081138	Cadherin 7	Q9ULB5	18	65750252-65890341	Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 16.7	Cell type enriched	Detected in some	7	Muller glia cells: 44.1	Cancer enhanced	Detected in single		prostate cancer: 0.5	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 17.3;HEK 293: 3.2;Karpas-707: 6.3;RH-30: 8.3;U-87 MG: 3.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA061419	Supported											HPA061419: AB_2684511	unprognostic (2.81e-3)		unprognostic (6.95e-2)		unprognostic (2.26e-1)			unprognostic (2.24e-2)	unprognostic (3.45e-2)	unprognostic (2.41e-1)	unprognostic (3.95e-3)	unprognostic (2.88e-1)	unprognostic (4.28e-4)	unprognostic (2.70e-2)	unprognostic (1.49e-1)		unprognostic (1.72e-1)	0.4	0.6	2.6	0.3	4.3	0.6	0.4	15.3	7.5	0.3	0.3	0	0	0.4	0.3	0.6	0.3	0.3	0.4	0.4	0.5	2.5	0.3	0.6	0.4	0.3	1.5	2.1	1.6	0.3	0.3	1.2	0.3	16.7	3.6	0.5	1.3	0.4	1.9	1	0.5	0.3	0.2	1.3	0.4	0.3	1.8	0.1	0.7	0.5	0	0.4	0.3	0.2	0.8	0.5	1.9	0.4	0.6	0.4	0.1	0	0.2	17.3	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	0	0	3.2	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	6.3	0	0	0	0.1	0.7	0	0.3	0.1	8.3	0	0	0	0.1	0.4	0	0	1.8	0.3	1.3	0	0	0	0.1	0	0	1.1	0	0	3.9	0	0	1.2	0.4	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0	0.8	0.4	0.4	1.9	0.6	0.3	0.5	0.2	0.1	2.6	4.3	15.3	5.2	0.5	2.5	1.5	2.1	16.7	0.1	0	0	0	0.5	0	2	0.8	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0.8	0.8	0	0	0	0	3.4	0	0	1.7	0.6	0	0	0	0	44.1	0	0	0	0	4.1	6.5	0	0.7	0.7	0	0	0	0	0.1	Muller glia cells
TRPM3	GON-2, KIAA1616, LTRPC3	ENSG00000083067	Transient receptor potential cation channel subfamily M member 3	Q9HCF6	9	70529063-71446904	Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	brain: 36.6;kidney: 28.0;retina: 105.2	Cell type enriched	Detected in many	4	Muller glia cells: 278.6	Cancer enhanced	Detected in single		renal cancer: 0.9	Low region specificity	Detected in all			Cell type enriched	Detected in single	16	NK-cell: 2.1	Lineage enriched	Detected in single	16	NK-cells: 2.1	Cell line enriched	Detected in some	4	HAP1: 19.4	Low region specificity	Detected in all							HPA072650, HPA074393	Enhanced		Approved	Vesicles						Vesicles		HPA072650: , HPA074393: 	unprognostic (3.74e-1)	unprognostic (6.30e-2)	unprognostic (4.79e-2)	unprognostic (4.81e-2)	unprognostic (1.38e-2)	unprognostic (8.88e-2)	unprognostic (1.49e-2)	unprognostic (2.19e-2)	unprognostic (1.11e-1)	unprognostic (1.89e-2)	unprognostic (6.10e-2)	unprognostic (1.15e-2)	unprognostic (1.82e-7)	unprognostic (3.51e-2)	unprognostic (5.64e-2)	unprognostic (1.74e-2)	unprognostic (1.50e-2)	0.9	1.7	6	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3	0.7	1.3	1.3	1.4	9.4	6	28	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5	1.1	0.8	0.7	1	8.1	1.1	1.6	5.3	5.9	0	2.1	0	0.6	0.8	0.5	0	0	0	0	2.1	0.1	0	0	0	1.1	0.1	1.3	3	0	0.1	0	0	0.1	0.1	0	0	0.1	0.1	0	0	19.4	0	0.1	0	0.1	0.1	1.5	0	0.3	0	0	0	0	0	0.3	2.7	0.2	0	0	1.2	4.5	0	0	0	1.4	0	0.1	0	0.2	0	1	0	1.3	0	0.2	0	0.4	0.2	0	0	3.6	0	0.1	3.5	0	0	0	0	0.5	0	1.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	2.1	0	0	0	0	6	4.5	36.6	3.8	9.4	6	8.3	3.5	34.8	5.9	3	4	0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0	5	0	3.9	1.3	0	0	0.2	0	1.5	0.4	0	0	0.2	1.6	14.8	0.6	0	1.7	5.2	1.1	0	0	0	278.6	0.1	0	8.5	25.8	4.7	0	1	1.5	0.4	0.6	0.2	0.8	0	0.3	Muller glia cells
CYP26A1	CP26, CYP26, P450RAI, P450RAI1	ENSG00000095596	Cytochrome P450 family 26 subfamily A member 1	O43174	10	93073475-93077890	Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	liver: 23.2;retina: 7.3	Cell type enriched	Detected in some	9	Muller glia cells: 70.3	Cancer enhanced	Detected in many		testis cancer: 5.0	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	AF22: 37.6	Not detected	Not detected			Region enhanced	Detected in many		cerebral cortex: 6.8														unprognostic (2.80e-1)	unprognostic (4.21e-3)	unprognostic (5.65e-2)	unprognostic (2.94e-1)	unprognostic (2.16e-1)	unprognostic (4.90e-1)	unprognostic (4.17e-2)	unprognostic (6.22e-2)	unprognostic (3.35e-1)	unprognostic (4.89e-1)	unprognostic (1.11e-2)	unprognostic (6.24e-2)	unprognostic (2.04e-11)	unprognostic (1.84e-2)	unprognostic (2.04e-1)	unprognostic (1.22e-1)	unprognostic (4.11e-1)	0.1	0.3	0.3	0	0.6	0.1	0.3	0.4	1.8	0.3	0.1	0	0	0	0.6	0.4	0	0	0	0	0.6	0.3	0	23.2	0.1	0	0.2	1.4	0.1	0	0	0.2	0.8	0.3	0.1	0	7.3	0.1	0	0	0.1	0	0.1	0.1	0.2	0.1	0.2	0.2	1.2	0	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0.4	37.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0.1	0	0	0	5.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.9	0.3	0	0	0	0	0	3	0	0	0.2	0	0	0	0	0.2	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0.4	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0.4	1.8	0.6	0.3	0.2	1.4	0.3	0.2	0	0	0	0	0	1.2	0.3	0	0	0	0	2	0	0	0.1	0.1	0	0	0	0	0.5	0	0.1	0	8.1	0.1	0	0	0	0	0	0	0	0	0	0	70.3	0	0	0	0	2.1	0	0	0.5	1.1	0	6.4	0	0	0	Muller glia cells
METRN	C16orf23, MGC2601	ENSG00000103260	Meteorin, glial cell differentiation regulator	Q9UJH8	16	715115-719655	Predicted intracellular proteins, Predicted secreted proteins	Differentiation, Neurogenesis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 58.9	Cell type enriched	Detected in many	8	Muller glia cells: 554.6	Cancer enhanced	Detected in all		glioma: 69.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MCF7: 53.4;PC-3: 41.3	Region enriched	Detected in all	5	cerebellum: 549.1	Low region specificity	Detected in all			HPA051164	Approved		Approved	Nucleoplasm,Nuclear membrane,Cytosol	Secreted in brain					Nuclear membrane	Nucleoplasm, Cytosol	HPA051164: AB_2681369	unprognostic (1.60e-2)	unprognostic (3.49e-1)	unprognostic (4.47e-2)	unprognostic (2.96e-1)	unprognostic (1.45e-1)	unprognostic (7.49e-2)	unprognostic (1.82e-1)	unprognostic (2.59e-1)	unprognostic (8.13e-2)	unprognostic (2.35e-1)	unprognostic (2.12e-2)	unprognostic (3.32e-1)	unprognostic (5.03e-3)	unprognostic (3.62e-2)	unprognostic (1.26e-1)	unprognostic (3.09e-1)	unprognostic (2.17e-2)	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19	2.5	6.6	3.4	3	3.9	5	3.2	0.9	0.8	1	1.7	2.9	0.5	2.6	22.5	4.4	22.5	7.9	4.4	7.2	5.3	2.7	2.1	1.4	3.3	6.6	0.4	12.5	3.7	8.2	9.9	0.6	5.2	0.3	1.4	9.9	0.9	4.1	17	4.8	1.9	2.9	10.7	5.7	0.6	1.3	6.7	0.7	6.3	1.5	0.5	1.6	53.4	0.7	6.5	1.6	2.9	41.3	7.3	5.1	7.3	5.5	0.7	7	8.9	2.1	5.9	27.4	0.5	8.9	3.8	2.4	6.1	11.7	7.1	4.6	3.4	0.9	0.4	9.6	1.4	14.4	0	0.3	0.8	2.9	1	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0	1.7	1	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19	0	2.1	4.2	14.7	3.4	38.6	14	50.9	2.7	0	15.7	13.7	0.6	43.1	6.3	6.5	12.6	15	0	4.2	1.8	8.7	28.3	0	27.2	5.2	66.7	26.2	19	5.1	14.5	10.3	4.8	10.1	0	8.1	554.6	5.4	14.7	8.9	43.5	29.1	25.8	15.3	3.9	11.3	2.6	0.3	6.4	8.6	14.2	Muller glia cells
CRYM	DFNA40	ENSG00000103316	Crystallin mu	Q14894	16	21238874-21303083	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 23.7;brain: 61.3;heart muscle: 45.9	Cell type enriched	Detected in many	4	Muller glia cells: 521.3	Cancer enhanced	Detected in many		prostate cancer: 14.6	Region enhanced	Detected in many		basal ganglia: 61.3	Cell type enriched	Detected in single	26	plasmacytoid DC: 23.7	Lineage enriched	Detected in single	26	dendritic cells: 23.7	Cell line enriched	Detected in some	4	RPTEC TERT1: 31.2	Group enriched	Detected in many	12	amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0	Low region specificity	Detected in all			HPA019086, HPA030619	Enhanced		Supported	Cytosol					110000	Cytosol		HPA019086: AB_1847260, HPA030619: AB_2673551	unprognostic (1.32e-1)	unprognostic (2.93e-3)	unprognostic (8.96e-2)	unprognostic (1.44e-1)	unprognostic (2.13e-1)	unprognostic (4.62e-2)	unprognostic (2.88e-1)	unprognostic (5.75e-3)	unprognostic (2.81e-1)	unprognostic (7.37e-2)	unprognostic (2.05e-2)	unprognostic (5.95e-2)	unprognostic (2.11e-3)	unprognostic (7.79e-3)	unprognostic (2.49e-2)	unprognostic (1.87e-3)	unprognostic (1.31e-1)	1.4	0.5	7.6	0.5	61.3	0.5	1	15.6	21.2	1.8	2.2	0	0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1	4.8	0.3	4	1.4	1	2	0.9	0.5	0.6	1.6	1.2	0	0.5	0	1.5	8.3	0.8	0.9	23.7	0	0	0	0	0.3	0	1.2	0	0	0	0.1	0.2	0	0.8	0	0	0	0	0.1	0.3	0	0.6	0.2	1.6	0	0	0	0.4	7.2	0	0.7	0	0	0.7	0.3	0	0.3	0.5	0	0	0.1	0	0.1	0.2	0.1	0	0.3	3.2	0.5	0.1	0	0	0.2	31.2	0	1.2	1.7	0	0	1	1.7	0	0	0	0.2	0.2	2.7	0	0	0	0.1	6.5	0	0	0	0	0	0	0	0	0.5	0	0	0	0.9	0	0	0	0	0	23.7	0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1	15.5	0.1	1.2	0	15.3	1.5	24.8	2.1	5.8	124.1	5.1	20.1	22.7	14	3.9	0	14.9	0.1	17	1	5.3	0	0	0	2.2	17.1	1.1	6	0.1	1.6	12.6	0.6	0	9.6	0	0.9	32.1	1	19.3	521.3	0.2	0	0	111.6	17.7	0	1	4.4	6.3	1.1	0.1	0	7.9	58.9	Muller glia cells
NPVF	C7orf9, RFRP	ENSG00000105954	Neuropeptide VF precursor	Q9HCQ7	7	25224570-25228486	Predicted secreted proteins		Neuropeptide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	30	brain: 9.5;lymphoid tissue: 2.9;retina: 7.0	Cell type enriched	Detected in some	44	Muller glia cells: 336.5	Not detected	Not detected			Region enriched	Detected in single	95	hypothalamus: 9.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Region enriched	Detected in single	17	hypothalamus: 7.2	Region enriched	Detected in some	4	hypothalamus: 3.8	HPA041733	Enhanced				Secreted in other tissues							HPA041733: AB_10794524																		0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	336.5	0	0	0	0	7.7	0	0	0	0	0	0	0	0	0	Muller glia cells
LHX2	hLhx2, LH-2	ENSG00000106689	LIM homeobox 2	P50458	9	124001670-124033301	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 44.7;retina: 17.0	Cell type enriched	Detected in some	9	Muller glia cells: 245.9	Group enriched	Detected in many	5	cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5	Group enriched	Detected in many	6	amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2	Group enriched	Detected in many	5	amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7	Group enriched	Detected in many	6	amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5	HPA000838		Supported	Approved	Nucleoplasm						Nucleoplasm		HPA000838: AB_2666109	unprognostic (3.60e-3)	prognostic favorable (9.52e-4)	unprognostic (3.52e-1)	unprognostic (9.97e-2)	unprognostic (1.29e-1)	unprognostic (1.12e-2)	unprognostic (6.37e-3)	unprognostic (1.07e-1)	unprognostic (4.59e-2)	unprognostic (3.24e-1)	unprognostic (2.96e-1)	unprognostic (1.32e-2)	unprognostic (4.66e-15)	unprognostic (1.72e-1)	unprognostic (2.92e-1)	unprognostic (2.46e-2)	unprognostic (1.77e-1)	0.9	1	30.7	1.1	20.5	0.9	1.1	0	44.7	0.8	0.9	4.7	0	1	0.8	0.8	0.8	0.8	1	0.8	23.6	2.4	0.8	6.1	0.9	1.1	1.5	16.1	1.1	0.8	0.8	4.6	5.1	0	0.8	1.1	17	1.1	0.8	0.8	2.2	0.9	0.8	0.2	0.9	0.9	4	4.2	0	0.8	0	1.1	0.9	0	0	0	0.5	0.1	0	0.1	0	0	4.9	0.1	15.7	0	0.2	1.6	0.4	0.2	1.2	0.1	4.9	0	0.1	2.1	0.9	12.3	0.1	15.7	0	0.6	0	3.4	0	10.9	0.2	1	0	0.1	0	0	0	0	0	0	0	0	0	1.8	7.8	0	0.1	19.5	0	4.6	4.2	0	0	0	0	6.4	0	4	0	0	0.1	5.6	2	0	10.2	0.4	2.9	0.7	0.2	3.2	0	0.6	2.2	1.2	0	0	0.2	0	0.1	0	0	0.1	0	0	0	0	0.1	0.5	0	0	0	0.1	0	30.7	20.5	0	26.6	23.6	2.4	1.5	16.1	0	4.2	0	0	0	0	0	2.7	0.4	0	0	0	0	2	0	0	0	28.3	0	0	0	0	8.3	0	0	0	0	3	7.9	0	6.7	0	16	0	0	0	0	0	245.9	0	0	0	0	6.2	0	0	1	0.6	0	0.1	0	0	0	Muller glia cells
SORCS1	sorCS1	ENSG00000108018	Sortilin related VPS10 domain containing receptor 1	Q8WY21	10	106573663-107164534	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		thyroid gland: 18.5	Cell type enriched	Detected in some	4	Muller glia cells: 59.3	Cancer enhanced	Detected in some		melanoma: 3.2	Low region specificity	Detected in many			Cell type enriched	Detected in single	24	intermediate monocyte: 2.4	Lineage enriched	Detected in single	24	monocytes: 2.4	Group enriched	Detected in some	12	RH-30: 33.9;SH-SY5Y: 44.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA011948	Approved		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA011948: AB_1857366	unprognostic (5.86e-3)	unprognostic (8.45e-3)	unprognostic (1.55e-2)	unprognostic (1.67e-1)	unprognostic (1.13e-1)	unprognostic (1.36e-1)	unprognostic (1.05e-2)	unprognostic (2.92e-2)	unprognostic (3.52e-2)	unprognostic (5.58e-2)	unprognostic (6.82e-3)	unprognostic (5.81e-2)	unprognostic (6.48e-4)	unprognostic (2.51e-2)	unprognostic (8.89e-3)	unprognostic (2.22e-1)	unprognostic (2.69e-4)	1.4	5.8	6	4.5	14.1	0.4	1.8	0.5	13.2	2.2	10.7	1.1	1.9	1.4	2.1	1.2	2	3.2	2.8	4.2	2.6	4.7	8	0.5	0.5	1.9	2.1	6.6	1.2	3	0.6	1.2	0.4	3.3	2.7	3.6	6.5	2.4	4.9	0.8	2.3	4.5	2.7	2.1	1.7	3.4	2.3	2.7	0.2	18.5	1.1	2.7	4.7	3.8	0	0	0	2.4	0	0	0	0	0	1.3	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0.6	0	0	0	0	0.5	0	0	0	33.9	0	0	0	0	44.4	0	0	1.3	0.1	0	0	0	0	0.2	2.5	0	0	0	0	0	0	3.3	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6	14.1	0.5	11.3	2.6	4.7	2.1	6.6	3.3	2.7	0	0.3	0	0	0.6	1.8	1.8	0	0	1.2	0	0	0	0	0.6	14.7	0	0	0	0	0	0.8	0	0	0	0.2	1.6	0	0	0.3	3.4	0	0	1.7	0	0	59.3	0.1	0	0.4	2.2	1.7	0	0	0	1.5	0.1	0	0	0	0	Muller glia cells
NR2E1	TLL, TLX, XTLL	ENSG00000112333	Nuclear receptor subfamily 2 group E member 1	Q9Y466	6	108166058-108188809	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding, Receptor, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	brain: 19.0	Cell type enriched	Detected in single	50	Muller glia cells: 39.7	Cancer enriched	Detected in single	14	glioma: 6.2	Low region specificity	Detected in many			Cell type enriched	Detected in single	11	neutrophil: 1.0	Lineage enriched	Detected in single	11	granulocytes: 1.0	Cell line enhanced	Detected in some		BEWO: 6.4;GAMG: 3.0;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.2	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA036954, HPA055642	Uncertain		Approved	Nuclear bodies						Nuclear bodies		HPA036954: AB_10670958, HPA055642: AB_2682871	unprognostic (3.43e-1)	unprognostic (1.41e-1)			unprognostic (1.77e-1)	unprognostic (9.60e-2)	unprognostic (6.27e-2)	unprognostic (6.00e-1)	unprognostic (1.78e-2)		unprognostic (7.31e-2)	unprognostic (8.64e-2)	unprognostic (9.59e-8)	unprognostic (2.87e-1)	unprognostic (2.49e-1)		unprognostic (3.07e-1)	0.6	1.1	14.5	0.6	16	0.8	0.8	0	19	0.6	0.6	2.8	0	0.7	0.6	0.6	0.6	0.6	0.6	0.7	10.8	4.3	0.9	0.6	0.6	0.7	3.5	7.5	0.7	0.7	0.8	0.1	0.7	0	0.6	0.6	3.3	1	0.6	0.7	0.9	0.6	0.6	0	0.7	0.7	0.8	4.1	0	0.7	0	0.6	0.7	0	0	0	1	0	0	0	0	0.1	0	0	0	0	0	6.4	0	0	0	0	1.2	0	0	0.1	0	3	0.1	0	0	0	0	2.2	1	0.1	0	0	0	0	0	0.1	0	0.2	0.2	0	0.3	0	0	0	0.1	0	0	0	0	0	0	1.6	0	0	0.4	0	0.1	0	0	0	0.2	0.1	0.1	0.1	0	0	0	8.2	0	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	14.5	16	0	10	10.8	4.3	3.5	7.5	0	4.1	0	0	0	0	0	0.8	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	39.7	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0	0	Muller glia cells
NDP	EVR2, norrin	ENSG00000124479	NDP, norrin cystine knot growth factor	Q00604	X	43948776-43973504	Disease related genes, Predicted secreted proteins	Sensory transduction, Vision, Wnt signaling pathway		Deafness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 40.4	Cell type enriched	Detected in some	8	Muller glia cells: 100.6	Cancer enhanced	Detected in many		glioma: 25.8	Low region specificity	Detected in all			Cell type enriched	Detected in single	14	memory CD4 T-cell: 1.7	Lineage enriched	Detected in single	14	T-cells: 1.7	Cell line enriched	Detected in some	17	U-87 MG: 41.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	Secreted to extracellular matrix					Vesicles	Nucleoplasm, Nucleoli	HPA003095: AB_1079457	unprognostic (1.12e-1)	unprognostic (7.12e-2)	unprognostic (2.27e-2)	unprognostic (2.55e-3)	unprognostic (6.84e-3)	unprognostic (1.51e-1)		unprognostic (9.09e-2)	unprognostic (2.29e-1)	unprognostic (1.22e-1)	unprognostic (1.86e-1)	unprognostic (1.40e-1)	unprognostic (3.02e-2)	unprognostic (2.22e-2)	unprognostic (1.47e-1)	unprognostic (1.13e-1)	unprognostic (2.87e-3)	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18	0.9	1.4	14	7.8	0.7	0.5	0.6	0.7	11	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0	1.2	0	0.7	1	1.7	0.1	0	0.1	0	0	1.7	0	0	0	0.1	0.1	0	0.4	0.6	0	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0.3	0.1	0	0	0.2	0	0	0	0	0.1	0	0.7	0	0	0.9	0	0	0.1	1.1	0.7	0	0	1.1	0	2.4	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0.1	0	0.1	1.2	0	0	0	41.2	0.4	2.4	0	0	0.1	0.1	0	0	0	1.7	0	0	0.1	0	0	0.1	0	0	0	0	0	17.3	18.6	14.6	15	14	7.8	11	10.9	13.1	12.2	0	0	0	0	0.1	0.5	0.2	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0.2	0.3	0	0	0	0.1	0	0	0	0	0.4	12.4	0	0	0	0	100.6	0.7	0	9.2	0	3.3	0	0.2	0	0	0.1	0	0	0	0.1	Muller glia cells
GFAP	FLJ45472	ENSG00000131095	Glial fibrillary acidic protein	P14136	17	44903161-44916937	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins			Disease mutation, Leukodystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	61	brain: 595.5	Cell type enriched	Detected in some	8	Muller glia cells: 48.9	Cancer enriched	Detected in some	368	glioma: 2468.0	Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 9.8	Group enriched	Detected in many	5	granulocytes: 9.8;NK-cells: 2.9	Cell line enhanced	Detected in many		U-87 MG: 9.6	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB000039, HPA056030, HPA063513	Enhanced	Supported	Supported	Intermediate filaments		No	No		220000000	Intermediate filaments		CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027	unprognostic (1.79e-2)	unprognostic (2.74e-1)	unprognostic (9.83e-2)	unprognostic (2.12e-5)	unprognostic (4.08e-1)	unprognostic (5.09e-1)	unprognostic (1.26e-1)	unprognostic (6.53e-2)	unprognostic (6.57e-3)	unprognostic (7.35e-2)	unprognostic (5.86e-2)	unprognostic (1.24e-1)	unprognostic (7.63e-2)	unprognostic (2.75e-5)	unprognostic (1.49e-1)	unprognostic (1.66e-1)	unprognostic (1.64e-1)	3	2.9	122.2	3.2	105.4	5.8	3	33.9	595.5	2.7	3	171	0	2.8	2.9	3	3.6	3.2	3.1	4	143	175.1	3	2.8	3	3.1	227	67.3	3	3	3.4	1.3	2.8	212.7	3	2.9	0	3.1	2.9	3.2	3.3	2.8	2.9	482	3	3	2.9	119	0	3	0	2.9	3.4	0	1.1	0.8	9.8	1.2	2.9	0.8	0.3	1.7	1.1	2	3.8	0	0.8	0.5	1.7	2.1	2.5	2.1	2.2	2.5	3.5	3.2	0.9	1.4	4.3	2.2	0.7	3	4.3	1.9	2.9	2.9	1.5	0.1	0.8	4.3	0.2	1.3	1.7	0	2.6	0	3.7	1.3	8.5	0.6	2.2	3	4.2	2.8	0.2	5.3	1.2	1.3	2.8	1.1	1.5	2.7	3	0.5	3.5	0.3	1.7	2.3	2.2	1.2	2.1	1.6	1.9	2.6	1.2	2.3	2.8	9.6	3.5	3.4	1.9	1.2	0.5	0.5	1.1	0.4	0.4	0.5	0.7	0.3	1.1	0.6	0.8	9.8	2.9	0.7	0.8	0.4	0.3	122.2	105.4	33.9	69.4	143	175.1	227	67.3	212.7	119	0	0	0	0	0	0.7	4.2	0	0	0	0	5.9	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.9	0	0	0	0	3.3	0	0	0	0.1	0	0	0	0	0.1	Muller glia cells
ABHD12B	BEM46L3, C14orf29	ENSG00000131969	Abhydrolase domain containing 12B	Q7Z5M8	14	50872160-50904970	Predicted intracellular proteins		Hydrolase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 10.0;retina: 10.0;skin 1: 21.6	Cell type enriched	Detected in some	8	Muller glia cells: 136.7	Cancer enriched	Detected in many	5	testis cancer: 7.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		eosinophil: 2.3;neutrophil: 5.4	Lineage enriched	Detected in single	6	granulocytes: 5.4	Cell line enhanced	Detected in some		HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9	Region enriched	Detected in single	5	thalamus: 2.3	Low region specificity	Detected in many			HPA002873	Uncertain		Uncertain	Nucleoplasm						Nucleoplasm		HPA002873: AB_2220573	unprognostic (6.61e-2)	unprognostic (3.49e-2)	unprognostic (2.92e-3)	unprognostic (1.99e-3)	unprognostic (4.63e-2)	unprognostic (1.17e-2)	unprognostic (1.62e-2)	unprognostic (2.09e-1)	unprognostic (4.31e-2)	unprognostic (6.27e-2)	unprognostic (3.30e-1)	unprognostic (3.35e-1)	unprognostic (1.70e-3)	unprognostic (3.16e-2)	unprognostic (9.62e-2)	unprognostic (3.18e-3)	unprognostic (1.68e-1)	1.1	0.2	2.4	0.4	10	2.4	2.8	0.3	5.2	0.2	1.5	5.4	0.3	0.2	0.8	0.4	0.7	2	0.4	0.5	1.4	1.2	0.6	0.2	0.8	0.4	2.2	2.7	0.3	1.1	1.3	0.3	0.4	2.2	0.3	2.4	10	0.2	0.2	0.2	21.6	0.3	0.2	0.7	0.2	0.2	1.2	3.9	0	0.4	0	0.3	0.2	0.2	0	0.1	5.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0	0	0	0	0	0	0	1.3	0	0	1.4	0.5	0.7	1	0	0	0	0	0	0	0	0	0	0	0	0	2.4	1.6	0	0	0	2	0	0	0	0	1.3	0	0	0	2.9	1.3	1.9	0	0	0	0	0	0	0	0.2	0	0	0	0.8	0.9	2.3	0	0.1	0	0	0	0	0.1	0	0	0	5.4	0	0.1	0	0	0	2.4	10	0.3	5.2	1.4	1.2	2.2	2.7	2.2	3.9	0	0	0	0	0.3	3.3	1.4	0	14.7	0	1.8	2	0	0	0	6.1	0	0	0	0	0	0.2	0	1.1	0	0.1	0	0	0	0	2.8	1.1	0	0	0	0.9	136.7	0	0	0	0	16.9	0	0	0.2	0.2	1.3	0.2	0	1.6	0.1	Muller glia cells
DCLK1	DCAMKL1, DCDC3A, DCLK, KIAA0369	ENSG00000133083	Doublecortin like kinase 1	O15075	13	35768652-36131306	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Neurogenesis	Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 76.5	Cell type enriched	Detected in many	4	Muller glia cells: 84.2	Cancer enhanced	Detected in many		glioma: 12.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB012405, HPA015040, HPA015655	Enhanced		Approved	Nucleoplasm,Cytosol					11000	Nucleoplasm	Cytosol	CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265	unprognostic (2.29e-1)	unprognostic (2.56e-1)	unprognostic (7.45e-2)	unprognostic (1.30e-2)	unprognostic (1.99e-1)	unprognostic (2.35e-2)	unprognostic (1.48e-1)	unprognostic (3.30e-2)	unprognostic (1.66e-1)	unprognostic (1.74e-1)	unprognostic (7.72e-2)	unprognostic (2.85e-1)	prognostic unfavorable (4.42e-4)	unprognostic (1.93e-3)	unprognostic (1.29e-1)	unprognostic (1.34e-1)	unprognostic (1.14e-4)	13.9	3.3	14.3	4.2	25	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17	10.4	4.6	2.5	2.2	8.5	0	2.1	1.4	2.9	5	3.5	0	0	0	0	0	0	0	0	0.2	3.8	0	16.7	15.8	0	0.1	0.2	0.1	0.1	0	0	0	0	12.9	19.8	0	10	0.2	0	0	0.6	0	0.4	0	0.6	0	0	14.6	7.3	0.3	0.2	0	0.1	0	0	0	0.2	0	0	0	20.7	0	0.2	0	1.1	0	0.5	0	4.1	2.5	0	0	1.2	6.1	0	0	0	0	3.4	4.3	0.7	0.1	0	0	1.4	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.3	25	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5	8.9	1.1	0	1	13.5	2.2	5.1	0	4	4.5	3.5	3.9	0	0	0	1.3	2.9	0	0	0	0	9.3	0.5	0	0	0.1	9.5	0	0.6	0.3	0.9	19.2	0	13.5	0	0	84.2	0.3	0	3.9	0.2	2.1	6.5	16.8	1.6	0.7	8.4	0	0	0	1.3	Muller glia cells
RAX	RX	ENSG00000134438	Retina and anterior neural fold homeobox	Q9Y2V3	18	59267035-59274086	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Disease mutation, Microphthalmia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	pituitary gland: 12.9;retina: 45.2	Cell type enriched	Detected in some	6	Muller glia cells: 461.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 1.4;HEK 293: 1.4;HMC-1: 6.1;SH-SY5Y: 3.2;THP-1: 1.4	Not detected	Not detected			Not detected	Not detected																	unprognostic (4.14e-2)				unprognostic (1.79e-1)		unprognostic (3.76e-3)	unprognostic (2.28e-1)	unprognostic (2.22e-1)				unprognostic (1.33e-1)	unprognostic (3.46e-1)			0	0	0	0	0.1	0	0	0	0.6	0	0	1.4	0	0	0	0	0.1	0	0	0	0.4	0.2	0	0	0.1	0.1	0	0	0	0	0	12.9	0	0.1	2.1	0	45.2	0	0	0	0.5	0	0	0.9	0	0	0.5	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	1.4	0	0	0	0	0	6.1	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0	3.2	0	0	0	0.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.6	0.4	0.2	0	0	0.1	0.1	0	0	0	0	0.5	3	1	0	0	0	0	78.5	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	461.5	0	0	0	0	16	0	0	0	0.1	0	0	0	0	0	Muller glia cells
SOX3	PHP	ENSG00000134595	SRY-box 3	P41225	X	140502985-140505116	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		fallopian tube: 18.2;testis: 12.4	Cell type enriched	Detected in single	8	Muller glia cells: 4.3	Cancer enhanced	Detected in some		glioma: 2.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA054720, HPA075003			Enhanced	Nucleoplasm						Nucleoplasm		HPA054720: AB_2682584, HPA075003: AB_2686727					unprognostic (6.04e-2)					unprognostic (3.75e-1)			unprognostic (8.62e-3)	unprognostic (8.03e-2)	unprognostic (1.57e-1)	unprognostic (5.27e-3)		0.3	0.5	2.6	0.3	2.7	0.3	0.3	0.6	2.6	1.5	0.3	5	0	0.3	0.6	0.3	0.3	18.2	0.3	0.3	2.2	5	0.3	0.3	0.3	0.3	2	1.8	4.7	0.3	0.4	3.2	0.3	3.6	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.3	0.3	2.3	0.3	0.3	12.4	0.6	0	0.5	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	7.8	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	18.6	0	0	0	0	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	2.7	0.6	2.6	2.2	5	2	1.8	3.6	0.6	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	4.3	0.1	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	Muller glia cells
CHRND	ACHRD	ENSG00000135902	Cholinergic receptor nicotinic delta subunit	Q07001	2	232525993-232536667	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	skeletal muscle: 49.1	Cell type enriched	Detected in single	11	Muller glia cells: 4.3	Cancer enriched	Detected in single	7	head and neck cancer: 1.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	72	RH-30: 43.8	Not detected	Not detected			Region enriched	Detected in single	7	olfactory region: 1.4	HPA056404, HPA065404			Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA056404: AB_2732603, HPA065404: AB_2732734				unprognostic (1.69e-2)	unprognostic (7.93e-2)	unprognostic (3.28e-3)	unprognostic (7.75e-3)	unprognostic (6.04e-2)	unprognostic (1.10e-1)	unprognostic (7.25e-2)	unprognostic (1.90e-1)		unprognostic (4.97e-8)	unprognostic (7.52e-2)	unprognostic (2.86e-1)	unprognostic (2.46e-1)		2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	49.1	0.1	0	0	0	0	0	0.3	0	0	0	1.9	0.1	0	0	0	0.3	0.1	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	43.8	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Muller glia cells
PCDH8	ARCADLIN, PAPC	ENSG00000136099	Protocadherin 8	O95206	13	52842889-52848641	Plasma proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 20.6	Cell type enriched	Detected in some	7	Muller glia cells: 31.8	Cancer enhanced	Detected in some		glioma: 1.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	AF22: 23.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA010509	Uncertain		Uncertain	Golgi apparatus,Cytosol						Golgi apparatus	Cytosol	HPA010509: AB_10601384	unprognostic (3.50e-3)	unprognostic (6.48e-2)	unprognostic (1.40e-1)	unprognostic (9.11e-4)	unprognostic (2.12e-2)	unprognostic (1.97e-2)		unprognostic (7.01e-2)		unprognostic (1.13e-1)	unprognostic (1.17e-1)	unprognostic (3.59e-1)		unprognostic (1.21e-2)	unprognostic (1.07e-1)	unprognostic (1.32e-1)		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1	1.1	0	0.9	1	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0	1.4	0	0.8	0.9	0.9	0	0	0.8	0	0	0	0	0	0	23.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	4.8	0	0	1.7	0	0	0	0	5.2	0	0	0	0	0.9	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5	0	0	0	2.5	0.1	4.4	1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	31.8	0	0	0.4	0	0.9	0	0	1.4	0.9	0	0	0	0	1.3	Muller glia cells
EGF		ENSG00000138798	Epidermal growth factor	P01133	4	109912884-110012266	Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins		Growth factor	Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8	Cell type enriched	Detected in some	6	Muller glia cells: 38.3	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enriched	Detected in single	4	neutrophil: 1.7	Lineage enriched	Detected in single	4	granulocytes: 1.7	Cell line enhanced	Detected in some		EFO-21: 8.2;SK-BR-3: 14.9;U-251 MG: 4.7	Low region specificity	Detected in single			Low region specificity	Detected in many											209000	25000				unprognostic (2.83e-2)	unprognostic (1.02e-2)	unprognostic (8.50e-3)	unprognostic (1.88e-3)	unprognostic (4.24e-2)	unprognostic (1.64e-3)	unprognostic (5.06e-4)	unprognostic (8.30e-2)	unprognostic (2.21e-3)	unprognostic (4.25e-2)	unprognostic (1.80e-2)	unprognostic (2.95e-1)	unprognostic (7.72e-3)	unprognostic (4.64e-5)	unprognostic (2.63e-1)	unprognostic (9.80e-5)	unprognostic (3.92e-3)	0.8	0.1	0.4	0	0.4	0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0	0.6	0	1.2	0.7	0	41.2	0	0.4	0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0	0.2	0.2	0	1.2	4.5	0.4	0.4	0.5	0	0.4	1.7	0	0	0	2.6	0.2	0.3	2.4	0.1	0	0.1	0	0.6	1.5	0.8	0.5	0.1	0.1	0	8.2	0.8	2.1	0	0.3	0	0.6	0.1	0.4	0.1	0.9	1.5	0	0	0	0.2	0	0	0	1.8	0	0	1.6	0.2	0.8	0.1	0	0	2.9	0	0.6	0.2	0.1	0.7	0.7	0.2	0	0	0	14.9	0.5	1.8	3.5	0	0	1.3	2	0	4.7	0	0	0	1.4	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0.4	0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2	0	0	0	0.1	0.9	0.6	6.2	0	0	0	0	0	0	6.6	0.2	2.2	0	0.4	0	4.9	0	0	1.5	0	0	0.1	1.6	0	0	0	1.4	0	0	0	0	0	38.3	1.6	0	0	1.2	1.1	0	0	0.5	0.3	1.3	0	0	1.6	0.1	Muller glia cells
RLBP1	CRALBP	ENSG00000140522	Retinaldehyde binding protein 1	P12271	15	89209869-89221751	Disease related genes, Predicted intracellular proteins	Sensory transduction, Transport, Vision		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	retina: 164.1	Cell type enriched	Detected in some	43	Muller glia cells: 2424.2	Group enriched	Detected in some	30	glioma: 3.7;melanoma: 7.4	Group enriched	Detected in many	4	amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7	Group enriched	Detected in some	7	basophil: 3.3;neutrophil: 1.9	Lineage enriched	Detected in single	9	granulocytes: 3.3	Cell line enriched	Detected in single	48	SK-MEL-30: 21.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA042051, HPA044083	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol						Cytosol	Nucleoplasm, Centrosome	HPA042051: AB_2732495, HPA044083: AB_2678802	unprognostic (3.19e-2)	unprognostic (2.66e-1)	unprognostic (1.86e-1)	unprognostic (1.25e-1)	unprognostic (8.68e-2)	unprognostic (1.76e-1)		unprognostic (8.24e-3)	unprognostic (5.21e-2)	unprognostic (3.17e-1)	unprognostic (2.63e-2)	unprognostic (1.76e-1)		unprognostic (2.78e-1)	unprognostic (1.13e-1)		unprognostic (8.42e-2)	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0	0	3.3	0.3	0	0	0.1	0	0	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0.3	0	0	0	0	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.9	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	3.3	0.3	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0.1	6.9	10.6	0.6	7	3.7	1.3	1.6	0.6	0.4	0.1	0	0	0	0	0	17.2	0.3	0	0	0	0	37.3	3	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0.3	4.8	0	0	0	0	0	0	0	3.6	0	2424.2	0	0	0	0	56.9	0	0	0.1	0	0	16.7	0	0	0	Muller glia cells
STAC2	24b2	ENSG00000141750	SH3 and cysteine rich domain 2	Q6ZMT1	17	39210536-39225872	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ductus deferens: 94.0;seminal vesicle: 101.5	Cell type enriched	Detected in many	11	Muller glia cells: 446.6	Group enriched	Detected in many	7	breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA076925			Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA076925: 	unprognostic (1.70e-3)	unprognostic (1.05e-1)	unprognostic (3.09e-2)	prognostic unfavorable (4.05e-5)	prognostic unfavorable (5.61e-4)	unprognostic (1.42e-1)	unprognostic (8.66e-2)	unprognostic (2.94e-2)	unprognostic (1.17e-2)	prognostic unfavorable (6.66e-4)	unprognostic (1.12e-2)	unprognostic (5.16e-2)	unprognostic (2.35e-3)	unprognostic (2.05e-2)	unprognostic (1.94e-1)	unprognostic (3.54e-2)	unprognostic (3.17e-1)	2.4	0.9	4.2	1	7.4	0.7	29.7	9.5	21.9	4	0.9	0	94	0.9	2.5	13.9	0.8	1.4	0.8	1	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0	0.7	0	0.8	0.8	0.9	0	0	0	0	0	0	0	0	0	0.4	0.7	0	0	0	0	0	0	0.2	0	0	0	0.4	0	8.3	0	3.3	0	0	0	0.4	0	25.8	0	0	0	0	0	0	3.8	0	0.1	0	0.7	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	2	0.2	2.7	0	0.2	0	0	0	0	0.2	0	0	0	0	0	11.8	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2	3	8	0	1.2	0.3	4.8	2.9	0	2.7	4.5	3.5	9.8	0.1	5	0	0.1	0.4	0	0	0	0.2	0.6	0.3	0	0	0.1	17.5	0	0	0	0	2.6	0	40.5	0	0	446.6	0	0	0	0	11.1	0	3.4	0.2	0.9	1.5	0.2	0	0	0.1	Muller glia cells
ILDR2	C1orf32	ENSG00000143195	Immunoglobulin like domain containing receptor 2	Q71H61	1	166895711-166975482	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 14.6;testis: 18.0	Cell type enriched	Detected in some	8	Muller glia cells: 116.0	Cancer enhanced	Detected in some		glioma: 4.3	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA012545, HPA012815	Uncertain		Approved	Plasma membrane						Plasma membrane		HPA012545: AB_2126894, HPA012815: 	unprognostic (9.14e-2)	unprognostic (5.05e-2)	unprognostic (8.27e-2)	unprognostic (2.16e-1)	unprognostic (5.89e-2)	unprognostic (5.33e-2)	unprognostic (2.89e-5)	unprognostic (2.09e-1)	unprognostic (8.55e-2)	unprognostic (4.51e-2)	unprognostic (1.52e-1)	unprognostic (2.58e-1)	unprognostic (9.17e-2)	unprognostic (5.87e-3)	unprognostic (4.92e-2)	unprognostic (1.64e-1)	unprognostic (1.36e-1)	0.8	1.1	9.8	0.9	6.4	1.4	0.5	2.1	14.6	0.7	2.9	3.6	0.1	0.7	0.9	1.4	0.9	0.8	1.3	3.1	7.2	7.7	6.3	1.3	1.4	1	2.7	8	0.8	0.7	0.5	3.3	0.8	3.1	2.3	1.2	2.8	0.8	2.8	0.8	0.7	0.8	2	2.3	0.7	0.7	18	3.1	1.9	0.9	0	1.1	0.9	0.3	0	0.4	0.3	0	0	0.3	0.5	0	0	9.7	0	0	0	0.3	0	0	0	0	1.2	1	1.8	0.3	0	0.4	0	0	0	0	2.2	1.9	0	0	0.2	0	3.1	0.7	0	0	0	0	0	0	7.4	0	0.1	0.2	0	5.1	0	3.3	0.1	0	0	0.3	0.7	0.7	0.2	1.3	0	0	0	0	1	0	0.9	0	0	12.5	0	6.6	2.3	0	0.5	1.4	1.3	0.4	0.2	0	0	0	0	0	0	0	0.1	0.4	0	0.3	0	0.3	0	0	0.1	0	0.5	9.8	6.4	2.1	11.4	7.2	7.7	2.7	8	3.1	3.1	0	0	0	0	0	3.9	3.2	0	0	1.2	0	5.9	0	0	0	9.4	0	0	0	0.2	0.1	0	0	0	1.1	0.1	1.6	1.2	0	0	13.8	0.6	0	0	1	0	116	0.1	0	0	4.6	6.5	0	0.1	3.3	1.3	0	0.2	0	0.2	0	Muller glia cells
KLHL8	KIAA1378	ENSG00000145332	Kelch like family member 8	Q9P2G9	4	87160103-87240314	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		epididymis: 56.2	Cell type enriched	Detected in many	5	Muller glia cells: 205.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013856, HPA017762	Approved		Enhanced	Nucleoplasm						Nucleoplasm		HPA013856: AB_1852594, HPA017762: AB_2669660	unprognostic (2.93e-2)	unprognostic (4.91e-3)	unprognostic (3.44e-2)	unprognostic (4.66e-2)	unprognostic (1.18e-1)	unprognostic (3.27e-2)	unprognostic (2.12e-1)	unprognostic (4.46e-3)	unprognostic (3.27e-2)	unprognostic (2.06e-2)	unprognostic (1.13e-1)	unprognostic (3.46e-1)	prognostic favorable (1.53e-5)	unprognostic (4.24e-3)	unprognostic (3.05e-1)	unprognostic (3.57e-3)	unprognostic (1.57e-3)	6.8	7.3	6.9	5.6	8.1	3	12	10	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5	7.4	7.7	7.2	11.4	10.3	9	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8	6.9	5.5	4.2	6.5	7	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5	6.5	5.8	10.5	4.7	9.6	7	5.6	8.4	4.5	5.6	6.6	9.2	5	9.5	6.8	6.2	4.6	2.8	11.1	8.3	12.2	9.1	7	11.6	4.4	5.4	8.2	19	7.3	8.8	6	8.6	8.7	5.5	6.7	7.3	14.9	8.7	5.8	7.2	22.7	9.6	2.6	14.8	2.3	8.6	9	5.8	9.5	6.8	22	7.7	5.5	13.5	6.2	4.1	4.7	14.1	6.2	7.2	8.8	7.6	7	13.1	8.5	16.9	5.4	9.1	7.8	1.9	12.1	7.3	3	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9	2.7	0.9	5	6.9	8.1	10	10.7	7.7	7.2	6.3	5.6	7.3	6.5	3	18.5	11.3	9.5	12.2	18.4	11.7	5.1	6.7	10.3	41.8	39.3	3.2	10	4.5	2.8	9.5	12.2	0	3.9	4.6	8.6	10.5	7	17.1	8.6	22.3	8.6	5.5	30.8	2.4	8.9	13.4	10.1	2.8	12	205.6	5	8.6	7.8	16.5	44.7	12.9	9.2	11.2	19.4	12.9	19.9	7.7	13.3	9.8	Muller glia cells
LIX1	C5orf11, Lft	ENSG00000145721	Limb and CNS expressed 1	Q8N485	5	97091867-97142872	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	4	brain: 35.9	Cell type enriched	Detected in some	16	Muller glia cells: 199.8	Cancer enhanced	Detected in many		glioma: 13.0	Low region specificity	Detected in all			Cell type enriched	Detected in some	5	naive B-cell: 5.9	Lineage enriched	Detected in single	9	B-cells: 5.9	Group enriched	Detected in some	11	RPTEC TERT1: 24.5;SuSa: 19.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058426	Uncertain		Approved	Vesicles,Cytokinetic bridge,Cytosol		Yes				Cytosol	Vesicles, Cytokinetic bridge	HPA058426: AB_2683715	unprognostic (3.18e-1)	unprognostic (4.53e-2)	unprognostic (9.46e-2)	prognostic unfavorable (2.48e-4)	unprognostic (8.96e-2)	unprognostic (6.60e-2)		unprognostic (1.34e-1)	unprognostic (4.70e-1)	unprognostic (7.63e-2)	unprognostic (1.58e-2)	unprognostic (3.52e-1)	unprognostic (2.01e-1)	unprognostic (4.88e-2)	unprognostic (2.16e-1)	unprognostic (1.26e-1)	unprognostic (9.61e-2)	1	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1	1.3	19.2	1	1.2	1.2	1.2	1	1.2	1.1	1.1	24.6	10.7	4.9	1	1.1	1.6	11.7	13.2	1	1	1	1.2	1.4	12.4	3	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13	0	6.5	0	1	1	0.2	5.9	0.1	0.6	0.1	0	0.2	0	0	0	2	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0	24.5	0	0	0	0	0	0	19.2	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.6	0.1	0	0.1	0	0.2	1.2	0.1	0	0	5.9	0.1	0.1	0.3	0	0	0.1	0	0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13	0	0	0	0	0	1.9	0.5	0	0	0	12.2	0	0	0	0	0	0	0	0	0	0	1.2	0.1	0	0	0.1	3.2	0	0	0	0	0	0	0	0	0	199.8	0	0	0	1.4	4.9	0	0.1	0	0	0	0	0	0	0	Muller glia cells
MEGF10	KIAA1780	ENSG00000145794	Multiple EGF like domains 10	Q96KG7	5	127290831-127465737	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion, Myogenesis, Phagocytosis		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.8	Cell type enriched	Detected in some	6	Muller glia cells: 48.7	Cancer enhanced	Detected in some		glioma: 3.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	AF22: 21.6;RH-30: 26.5	Low region specificity	Detected in all												Intracellular and membrane				27000000				unprognostic (7.02e-2)	unprognostic (4.50e-2)	unprognostic (1.02e-1)	unprognostic (2.26e-3)	unprognostic (8.91e-3)	unprognostic (1.59e-2)	unprognostic (1.35e-1)	unprognostic (1.16e-1)	unprognostic (1.99e-1)	unprognostic (2.13e-1)	unprognostic (1.52e-1)	unprognostic (1.41e-1)	unprognostic (1.76e-4)	unprognostic (5.28e-3)	unprognostic (2.59e-1)	unprognostic (9.36e-4)	unprognostic (1.17e-1)	1.3	5.1	9.8	1.2	12.9	0.9	2.8	3.3	24.6	1.8	1.4	25.8	0	1.2	2.8	2	1.2	1.2	1.1	1.5	11.6	5.6	1.1	1.8	1	1	21.7	10.4	1.2	0.9	0.9	2.4	1.2	12.2	2.8	1.5	2.4	5	3.7	7.3	1.1	1.3	1.6	14.8	1.2	1	1.9	23.1	0	1.1	2	1.5	1	0.4	0	0.3	0	0	0	0	0	0	0	21.6	0	0	0	0	0	1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	4.7	0	0.1	0.1	0	0	0	1.7	0	0	0	2.3	0	0	0	26.5	0	0	0	0	0	0	0	1.7	0.5	0	0	0	0	1.4	0	0	0	0	0	1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	9.8	12.9	3.3	10.8	11.6	5.6	21.7	10.4	12.2	23.1	0	0	0	0	0	2	0.8	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.1	0.5	0	0	0	7.9	0	0	0.3	0.8	0	0	0	0	0	48.7	0	0	0	0	1.6	0	0	0.3	0.4	0.1	0	0	0	0	Muller glia cells
PRSS35	C6orf158, dJ223E3.1, MGC46520	ENSG00000146250	Serine protease 35	Q8N3Z0	6	83512538-83525704	Enzymes, Predicted secreted proteins		Serine protease homolog		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 17.1;ovary: 16.3	Cell type enriched	Detected in some	55	Muller glia cells: 458.8	Cancer enhanced	Detected in some		testis cancer: 4.7	Low region specificity	Detected in many			Cell type enriched	Detected in some	9	MAIT T-cell: 17.1	Lineage enriched	Detected in single	172	T-cells: 17.1	Cell line enhanced	Detected in some		BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6	Low region specificity	Detected in all			Group enriched	Detected in many	4	amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7	HPA038787, HPA038788	Uncertain				Secreted in female reproductive system							HPA038787: AB_10675951, HPA038788: AB_2676208	unprognostic (6.17e-2)	unprognostic (8.75e-2)	unprognostic (1.19e-2)	unprognostic (2.63e-2)	unprognostic (1.16e-1)	unprognostic (4.03e-2)	unprognostic (3.70e-4)	unprognostic (6.08e-2)	unprognostic (1.18e-3)	unprognostic (2.33e-2)	unprognostic (7.01e-2)	unprognostic (9.07e-2)	unprognostic (3.88e-6)	unprognostic (7.15e-3)	unprognostic (5.81e-2)	unprognostic (2.82e-2)	unprognostic (3.54e-4)	2	3.8	7.7	1.3	11.3	0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2	3	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0	0.7	0.4	0.2	2	0.9	0	0	0	0	0	17.1	0.1	0	0.2	0.9	0	0	0	0	0.2	5.2	0.5	1	42.7	0	0	0	0.2	0	0	6.4	0	0.3	0	0.2	0	0	0	0.1	0	0	1.6	0	0.6	0	0.1	0	0	0	0	0.1	0	0	0	0.8	0.2	4.1	0	0	0	12.6	0	0	0.5	0	0	0	9.6	0	0	0	0.1	0.4	0	0	0	0	0	0.1	0	0	0	0	0	1	0	17.1	0	0.3	1.8	0	0	0	0	0	0	0	0	0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3	3	0.3	0	0	0	2.3	1.2	0	0	0	1.8	0	0.1	8.3	0.1	0	0	0	0	0	0	3.1	0	0	0	0.3	6.4	1.7	0	0	0	1.1	0	0	0	0	458.8	0	0	8.1	0	7.1	6.5	1.2	0	0.2	0	0.1	0	0	0	Muller glia cells
CLVS2	bA160A10.4, C6orf212, C6orf213, RLBP1L2	ENSG00000146352	Clavesin 2	Q5SYC1	6	122995971-123072927	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 39.9	Cell type enriched	Detected in some	5	Muller glia cells: 71.4	Cancer enhanced	Detected in single		glioma: 0.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	HEL: 14.7;SCLC-21H: 11.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043764	Uncertain											HPA043764: AB_10960281	unprognostic (1.35e-1)		unprognostic (3.28e-2)		unprognostic (4.68e-2)				unprognostic (3.60e-1)		unprognostic (2.38e-1)	unprognostic (7.04e-2)	unprognostic (1.43e-2)	unprognostic (5.72e-3)	unprognostic (9.60e-2)		unprognostic (8.71e-2)	0.7	2.8	5	0.9	9.6	0.7	0.8	39.9	22.6	2.1	1.1	0.6	0	0.9	3.1	0.7	0.8	0.7	0.8	0.7	5.8	3.9	0.7	0.8	0.7	0.8	3	10.2	0.7	0.7	0.7	6.3	0.7	8.5	7.9	1.1	0.1	0.8	1.1	0.7	0.8	0.9	2.8	1.3	0.7	0.8	1	1.8	0	0.7	0	0.7	1.3	0.6	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.6	0	0	0	0	0	0	0	11.5	0	0	0	0	0	0	0	0	0	0.9	0	0.1	0	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	9.6	39.9	22.6	5.8	3.9	3	10.2	8.5	1.8	0	0	0	13.8	0	3	1.1	0	0	0	0	0	0	0	0	4.9	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	71.4	0	0	0.4	0	4.5	0	0.5	0.1	0	0	0	0	0	1.8	Muller glia cells
PMP2	FABP8, M-FABP, MP2	ENSG00000147588	Peripheral myelin protein 2	P02689	8	81440326-81447523	Predicted intracellular proteins	Transport		Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	30	brain: 124.8	Cell type enriched	Detected in some	18	Muller glia cells: 30.0	Cancer enriched	Detected in some	59	glioma: 239.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 1.0;Karpas-707: 1.4;U-87 MG: 1.6;WM-115: 5.4	Not detected	Not detected			Group enriched	Detected in some	26	midbrain: 78.0;pons and medulla: 111.5															unprognostic (5.87e-2)			unprognostic (5.81e-2)	unprognostic (1.12e-2)		unprognostic (1.95e-1)	unprognostic (8.03e-3)	unprognostic (1.10e-2)	unprognostic (8.45e-2)	unprognostic (4.43e-2)		unprognostic (7.21e-2)	unprognostic (4.41e-1)		unprognostic (3.27e-3)	2.7	2.5	39.2	2.4	36.9	1.5	1.6	13.4	124.8	2.5	2.2	14.5	0	1.8	1.6	2.8	2	1.7	2.2	2.4	30.4	31.2	1.6	1.6	1.5	1.5	48.3	18.3	1.7	1.8	1.5	0	1.5	66.6	2	2	0	2.2	4.2	1.7	1.7	1.9	1.7	106.3	1.5	1.6	1.6	45.8	0	1.5	0	1.5	1.8	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0.1	0	0	1	0	0	0	0	0	0	0.2	0	0	0	0.6	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.3	0	0.1	0.8	0	0	0	0.1	0	0	0	0	0	0	0	1.6	0.1	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	39.2	36.9	13.4	27.8	30.4	31.2	48.3	18.3	66.6	45.8	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	30	0	0	0	0	1.2	0	0	0	0	0.1	0	0	0	0	Muller glia cells
SLC39A12	FLJ30499	ENSG00000148482	Solute carrier family 39 member 12	Q504Y0	10	17951839-18043292	Predicted membrane proteins, Transporters	Ion transport, Transport, Zinc transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	13	brain: 42.3;retina: 19.2	Cell type enriched	Detected in some	30	Muller glia cells: 85.4	Cancer enriched	Detected in single	8	glioma: 3.0	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-2 OS: 1.3	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.43e-2)				unprognostic (2.67e-1)	unprognostic (3.30e-1)		unprognostic (8.70e-2)	unprognostic (1.02e-1)		unprognostic (8.35e-2)	unprognostic (1.33e-1)	unprognostic (3.40e-6)	unprognostic (1.94e-1)	unprognostic (8.11e-2)	unprognostic (3.76e-2)		1.2	1	13.7	1	14.6	0.9	2.3	2.2	31.2	0.9	1	14.8	0	0.9	0.9	0.9	0.9	0.9	0.9	1	21.4	5.5	0.9	0.9	1	0.9	9.9	5.6	0.9	1.2	0.9	1.5	1.1	42.3	1	1.1	19.2	1	0.9	0.9	0.9	0.9	1	1.5	1	0.9	1.4	8.7	0	0.9	0	0.9	1	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0.3	0.1	0.5	0	0.5	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0.3	0.1	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	1.3	0.4	0.3	0.1	0	0	0.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.7	14.6	2.2	17.5	21.4	5.5	9.9	5.6	42.3	8.7	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0.5	0.3	0	0	0	0	85.4	0	0	0	0	2.9	0	0	0	0.6	0.1	0	0	0	0	Muller glia cells
RGR	RP44	ENSG00000148604	Retinal G protein coupled receptor	P47804	10	84245053-84259960	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer	Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	retina: 228.3	Cell type enriched	Detected in some	36	Muller glia cells: 1479.5	Cancer enhanced	Detected in single		glioma: 0.9	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		TIME: 4.0	Not detected	Not detected			Group enriched	Detected in many	5	midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2														unprognostic (9.28e-2)		unprognostic (1.05e-1)	unprognostic (1.37e-1)	unprognostic (9.53e-2)				unprognostic (4.57e-2)	unprognostic (1.57e-1)				unprognostic (1.59e-1)	unprognostic (1.97e-1)			0.4	0.4	6.6	0.5	6.1	1.3	0.6	0.4	18.1	0.5	0.4	0.6	0	0.3	0.5	1.1	0.6	0.3	0.3	0.3	3	2.2	0.4	0.4	0.4	0.6	3.2	1.3	0.5	0.3	0.2	0.4	0.4	1.1	0.5	0.6	228.3	0.6	0.4	0.6	1.1	0.5	0.2	0.2	0.5	0.4	1.2	0.7	0	0.4	0	0.3	0.3	0	0.9	0.9	2.2	0.8	1	0.7	0.1	0.6	0.7	0.8	1.6	0.5	0.5	0.4	0.4	0.4	1	0.4	1.5	0.2	0.8	0.7	1.2	1.3	1.2	0.3	0.7	0.2	0.5	0.2	0.3	3	1	0.2	1.4	1.7	0.3	0.7	0.5	1.2	2.6	0.3	0.7	0.6	1.4	0	1.2	0.5	0.9	1.5	0.2	0.2	0.5	0.5	1.5	0	1.5	0.3	0.4	1	0.7	1.4	1.2	0.2	0.1	4	1.6	2.1	0.8	0.3	1.2	0.2	1.2	0.3	1.3	1	1	0.8	0.8	0.6	0.8	0.4	0.8	0.7	0.5	0.3	0.9	0.6	0.6	2.2	1	0.4	0.9	0.2	0.1	6.6	6.1	0.4	7.3	3	2.2	3.2	1.3	1.1	0.7	0	0	0	0	0	19.7	0.3	0	0	0	0	29.5	0	0	0	7.1	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	7.9	0.3	0	0	0	0	1479.5	0	0	0	0	40.8	0	0	0.2	0.2	0	0	0	0	0	Muller glia cells
NPFFR1	GPR147, NPFF1R1, OT7T022	ENSG00000148734	Neuropeptide FF receptor 1	Q9GZQ6	10	70247329-70283676	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	6	brain: 34.9	Cell type enriched	Detected in some	6	Muller glia cells: 15.1	Cancer enhanced	Detected in some		ovarian cancer: 1.2	Group enriched	Detected in all	5	basal ganglia: 10.2;cerebellum: 34.9	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		U-2 OS: 4.8	Group enriched	Detected in some	6	basal ganglia: 16.1;hypothalamus: 7.3	Low region specificity	Detected in many			HPA037521	Uncertain											HPA037521: AB_2675520	unprognostic (1.73e-3)	unprognostic (7.29e-4)	unprognostic (2.12e-1)	unprognostic (3.50e-2)	unprognostic (2.07e-1)	unprognostic (8.66e-3)	unprognostic (1.37e-1)	unprognostic (1.48e-1)	unprognostic (4.14e-2)	unprognostic (3.51e-1)	unprognostic (9.62e-2)	unprognostic (6.78e-2)	unprognostic (5.84e-5)	unprognostic (1.37e-1)	unprognostic (3.93e-2)	unprognostic (1.78e-3)	unprognostic (1.04e-1)	0.6	0.5	1.9	1.8	10.2	1.3	0.9	34.9	2.6	0.9	0.6	2.6	0	0.8	1	1.2	0.4	1.6	0.6	0.4	2.7	4.1	0.5	0.5	1.3	2.5	2.2	4.1	0.8	0.3	0.9	0.4	0.4	4.7	0.6	0.8	5.4	0.4	1.1	1	1	0.8	0.4	4	1	1.4	4.7	2	0	0.6	0	1.4	0.6	0.7	1	1.2	2.4	2.2	1.3	0.6	2.6	1.1	0.8	0.9	0.7	0.8	1.3	0.7	0.3	0.4	0.3	0.3	1.3	2.3	0.8	0.7	1	0.4	1	2.2	1.2	0.7	0.7	0.9	1.1	1	1	0.8	0.8	1.3	0.7	1.1	0.5	0.8	0.9	0.9	1	0.9	0.9	0.5	0.9	0.7	0.9	0.8	1.9	0.3	0.9	0.8	0.5	0.8	0.8	0.8	0.8	0.8	1.2	0.4	0.8	0.5	0.6	1	0.9	4.8	0.8	1	0.7	0.8	0.5	0.6	0.9	0.7	2.4	2.2	0.4	0.5	0.7	0.5	0.5	0.5	0.4	1.2	1	0.6	0.6	1.9	1.3	0.4	0.9	0.4	2.6	1.9	10.2	34.9	2.6	2.7	4.1	2.2	4.1	4.7	2	0	1.3	0	1.2	1.4	0.7	0.8	2.5	0	0	1.8	0	0.1	0	0	0.3	0.3	0	0	0.2	0.1	1	1	2.3	0	0.1	0	0	0	0.3	1.1	0.6	1.1	0	0	0	15.1	0.1	0	0.4	0	1.5	0	1.4	0.2	0.4	1.8	0.9	0	0	0.8	Muller glia cells
G6PC2	IGRP	ENSG00000152254	Glucose-6-phosphatase catalytic subunit 2	Q9NQR9	2	168901240-168910000	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Gluconeogenesis	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	35	pancreas: 28.8;retina: 12.1	Cell type enriched	Detected in some	13	Muller glia cells: 70.6	Cancer enriched	Detected in single	92	pancreatic cancer: 9.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 1.0;SCLC-21H: 1.2	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (6.42e-2)				unprognostic (2.39e-2)		unprognostic (6.04e-2)		unprognostic (9.05e-2)		unprognostic (2.97e-1)		unprognostic (3.10e-2)	unprognostic (1.54e-2)	unprognostic (1.87e-1)			0	0	0.1	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	28.8	0	0	0	0.1	0	0	12.1	0	0	0	0.1	0.3	0	0	0	0.1	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.6	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	70.6	0.5	0	0	0	0.9	0	0	0	0	0	0	0	0	0	Muller glia cells
JAKMIP1	FLJ31564, Gababrbp, JAMIP1, MARLIN1	ENSG00000152969	Janus kinase and microtubule interacting protein 1	Q96N16	4	6026199-6200591	Predicted intracellular proteins, Predicted membrane proteins	Protein transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 19.5;brain: 37.4	Cell type enriched	Detected in some	7	Muller glia cells: 57.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	21	gdT-cell: 14.9;MAIT T-cell: 6.5;memory CD4 T-cell: 6.7;memory CD8 T-cell: 13.0;naive CD8 T-cell: 6.2;T-reg: 19.5	Lineage enriched	Detected in single	37	T-cells: 19.5	Cell line enhanced	Detected in some		Daudi: 9.8;JURKAT: 9.1;MOLT-4: 27.3;SCLC-21H: 12.3;U-266/70: 17.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044570	Uncertain											HPA044570: AB_2678995	unprognostic (4.79e-2)	unprognostic (3.46e-3)	unprognostic (4.90e-2)	unprognostic (1.73e-2)	unprognostic (5.34e-2)	unprognostic (3.86e-3)	unprognostic (6.16e-2)	unprognostic (6.69e-3)	unprognostic (4.25e-4)	unprognostic (7.14e-2)	unprognostic (4.57e-3)	unprognostic (1.13e-1)	unprognostic (3.70e-8)	unprognostic (1.85e-2)	unprognostic (3.15e-1)	unprognostic (4.23e-2)	unprognostic (2.96e-3)	1.3	8.5	15.7	2.3	35	2.6	1	2.5	37.4	1	1.5	2.7	0	1.2	1.1	1	1.1	1	1.7	1	15.6	14.7	1	1.1	1.9	4.7	10.8	13.3	1.6	1.6	1	3.8	1	7.2	7.4	1.3	0.1	2	1.1	1	1	1.7	1.3	4.3	2.9	1.7	5.9	7.6	0	1.4	0	1.8	2.3	0.1	0.1	0	0	0	0.5	19.5	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	9.8	0	0	1.7	0	0	0	0	5.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	9.1	0	0	0	0.2	27.3	0	2.2	0	1.7	1.4	0	0.7	0	0	12.3	4	0	0	0	0	0	0	0	0	0	0	0	17	2.8	0	0	0	0	0	0	0	14.9	0	6.5	0.1	6.7	13	0	0.1	0.5	6.2	0	0.5	0	0	19.5	2.5	15.7	35	2.5	21.2	15.6	14.7	10.8	13.3	7.2	7.6	0	0	0	0	0	1	0.8	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	1.4	0	0	0.1	3.2	0	0	1.5	2.2	0	0	0	0	0	57.2	0.2	0	0	0	5.9	0	0	0.9	3.7	0.1	0	8.7	0	0	Muller glia cells
WIF1		ENSG00000156076	WNT inhibitory factor 1	Q9Y5W5	12	65050626-65121566	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins	Wnt signaling pathway	Developmental protein	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.2;lung: 67.7;retina: 29.6	Cell type enriched	Detected in many	15	Muller glia cells: 2337.6	Cancer enhanced	Detected in many		endometrial cancer: 16.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 5.4;LHCN-M2: 2.5;NTERA-2: 7.0;SCLC-21H: 1.5	Low region specificity	Detected in many			Not detected	Not detected								Secreted to extracellular matrix								unprognostic (5.96e-3)	unprognostic (2.00e-1)	unprognostic (4.29e-3)	unprognostic (3.26e-3)	unprognostic (9.66e-2)	unprognostic (1.91e-1)		unprognostic (1.26e-2)	unprognostic (7.94e-2)	unprognostic (2.44e-1)	unprognostic (2.92e-2)	unprognostic (3.17e-1)	unprognostic (2.30e-5)	unprognostic (3.02e-1)	unprognostic (2.02e-1)	unprognostic (1.22e-1)	unprognostic (7.24e-3)	0.9	2.4	23.3	0.8	35.2	0.6	14.2	1.6	20.6	1.6	0.8	1	1.9	0.6	5.5	14.5	3.4	1.5	0.6	0.7	10.4	3.9	1	0.6	67.7	0.7	1.4	8.2	0.8	0.8	0.6	21.4	0.6	0.4	9.5	0.8	29.6	24.8	2.3	0.6	4.2	1.8	1.2	0.7	0.7	0.9	1	3.5	0	0.6	3.6	0.6	0.8	0.7	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	2.5	0.1	0	0.9	7	0	0	0	0	0	0	0	1.5	0.3	0	0.4	0	0	0.2	0	0	0	0	0.5	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.3	35.2	1.6	20.6	10.4	3.9	1.4	8.2	0.4	3.5	32.8	159.2	0	31.4	11.2	20.4	1.1	0	62.9	48.9	1.8	7.9	0	0	0	0.1	1.2	0	0	0	0	1.9	16	7	0	0	14.3	0	0	0	0	0	3.1	21.9	0	0	2337.6	0	0	0.4	0.8	66.4	0	3.6	0.5	0.2	9.3	0	0	0	0.5	Muller glia cells
PAQR6	FLJ22672, PRdelta	ENSG00000160781	Progestin and adipoQ receptor family member 6	Q6TCH4	1	156243321-156248117	Predicted intracellular proteins, Predicted membrane proteins		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	12	brain: 138.1	Cell type enriched	Detected in some	7	Muller glia cells: 71.8	Cancer enriched	Detected in all	6	glioma: 34.8	Low region specificity	Detected in all			Cell type enriched	Detected in some	6	NK-cell: 10.5	Lineage enriched	Detected in many	6	NK-cells: 10.5	Cell line enhanced	Detected in many		U-266/70: 20.9																No						unprognostic (1.64e-1)	unprognostic (2.27e-1)	prognostic unfavorable (1.60e-5)	unprognostic (7.42e-2)	unprognostic (5.52e-2)	unprognostic (4.50e-3)	unprognostic (4.75e-1)	unprognostic (2.25e-1)	unprognostic (2.57e-1)	unprognostic (3.13e-1)	unprognostic (4.25e-3)	prognostic unfavorable (1.99e-4)	prognostic unfavorable (1.58e-8)	unprognostic (1.26e-2)	unprognostic (1.34e-1)	unprognostic (8.82e-2)	prognostic favorable (1.86e-4)	2.1	3.6	42.5	2.2	38	7.6	2.2	8.7	71.6	2	2.7	102.9	0	2.8	2.3	2.9	2.5	2.2	2.9	2	48.1	37.6	2	2.1	2.1	2.1	82.7	16.1	1.6	1.6	2.4	1.2	2.2	72.5	3.5	2.3	0	3.2	3	2.1	11.5	3	2	138.1	2.3	3.1	2.5	46	0	2	0	2	2.5	0.3	0.8	1.6	0	0	10.5	1.2	0.1	1.8	2	3.3	3.4	0.6	0.5	8.2	0.2	0.5	0	0.2	1	6.4	3.3	1.5	0.5	0.2	5.8	0	0.7	0.4	1.9	2.7	2	1.7	0.9	0.3	0.6	5.3	1.6	2.6	2.4	2.4	3.3	0.3	6.7	1.5	9.5	0.6	6.7	0.2	1	3.8	1.1	0.9	1.4	0.7	1.5	2.3	10.7	2.9	5.8	0.7	0.7	3.8	6.9	10.8	1.1	0.5	1	5.3	1.7	0.5	20.9	4.6	2	0.2	7.5	0.9	0	0	0	0.4	0	1.2	0.8	0.6	0.2	0	0.1	0	0	0	10.5	0	1.6	0.1	0.1	42.5	38	8.7	34.4	48.1	37.6	82.7	16.1	72.5	46	0	0.3	0	0.2	1.1	3.2	2.8	0	0	0	0	0	0.1	0	0.5	0.2	0.7	0.7	0	3	0.1	0.6	0.7	1.1	0.9	0.5	6.4	4.1	0.6	0.6	0.6	0.3	0.7	0	0	0.4	71.8	1.3	0	2.1	0	10.3	0	0.2	0.7	0.4	1.3	0.2	4.6	0.9	0.4	Muller glia cells
FRZB	FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3	ENSG00000162998	Frizzled related protein	Q92765	2	182833275-182867162	Disease related genes, Predicted secreted proteins	Differentiation, Wnt signaling pathway	Developmental protein	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	retina: 265.8	Cell type enriched	Detected in many	12	Muller glia cells: 3160.2	Low cancer specificity	Detected in all			Region enriched	Detected in all	4	pons and medulla: 21.7	Group enriched	Detected in some	9	memory B-cell: 3.0;naive B-cell: 1.5	Lineage enriched	Detected in single	12	B-cells: 3.0	Cell line enhanced	Detected in some		AF22: 17.7;ASC diff: 8.6;NTERA-2: 7.2;SH-SY5Y: 6.1	Region enhanced	Detected in many		olfactory region: 69.9	Low region specificity	Detected in all								Secreted in other tissues				27000				unprognostic (5.39e-2)	unprognostic (1.48e-2)	unprognostic (1.18e-1)	unprognostic (1.79e-2)	unprognostic (1.93e-1)	unprognostic (2.09e-3)	unprognostic (1.64e-2)	unprognostic (2.38e-2)	unprognostic (4.67e-2)	unprognostic (8.58e-2)	unprognostic (5.41e-2)	unprognostic (2.34e-1)	prognostic unfavorable (8.97e-6)	unprognostic (3.53e-2)	unprognostic (1.05e-2)	unprognostic (6.04e-2)	unprognostic (3.21e-1)	4.4	1.4	2.8	4.8	5.4	0	5.1	2.9	3.5	7.1	5.1	3.3	2.6	4.5	5.5	3.5	3.6	2.8	12.9	8.4	2.8	2.8	5.5	2.2	3.7	4.8	3.6	3.4	4.4	2.4	0.6	11.3	44.3	21.7	4	6.6	265.8	5.1	5.4	8.4	4.3	4.7	10.5	2.9	28.2	12	4.2	2.3	3.1	5	3.1	3.4	3.5	6.2	3	0	0	0	0	0.2	0	0	0	17.7	0.2	8.6	0.2	0.1	0	0.8	3.1	2	0.3	0	0	0	0	0	0.1	0	0	3.2	0	0.1	0	0	0	2.3	0	0	0.7	0.6	0.2	0	0	0	0	0	0	1.8	0	0	0.1	7.2	0	0	0.6	0.7	0	0	0	1.1	6.1	0	0	0.1	0.5	0	0	0	0.3	0.1	0	0.2	0	0	0.3	0.1	0	0	0	0	0	0	0	0.2	3	0	0	0	1.5	0	0	0	0	0	0	0	0	2.8	5.4	2.9	3.5	2.8	2.8	3.6	3.4	21.7	2.3	0	0.3	0	0.4	7.2	34	2.2	0	0	2.3	0	31.4	4.3	0	0.1	0.3	2.1	1	0	7.5	3	28.8	1.7	0	0.9	6.8	25.4	1.2	4.3	1.5	1.9	3.4	0.8	232.8	0	99.8	3160.2	0.1	0	13.8	0	101	271.7	137	0.2	0	2.8	10.4	0	3.3	0.4	Muller glia cells
GABRB1		ENSG00000163288	Gamma-aminobutyric acid type A receptor beta1 subunit	P18505	4	46993723-47426444	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 34.5;pituitary gland: 14.7	Cell type enriched	Detected in some	25	Muller glia cells: 39.0	Cancer enhanced	Detected in single		glioma: 0.7	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 2.4;REH: 4.2;SCLC-21H: 1.1;U-87 MG: 6.8	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (3.11e-2)		unprognostic (7.56e-3)		unprognostic (5.10e-2)	unprognostic (1.83e-1)			unprognostic (1.11e-1)		unprognostic (4.98e-3)		unprognostic (8.16e-3)	unprognostic (6.22e-2)	unprognostic (2.72e-2)	unprognostic (2.34e-1)		1	1.3	19.9	1	34.5	0.9	1	14.7	27.9	1	1.2	2.7	0	1.6	1.2	1	1	1.2	1.2	6	16.3	4.2	1.8	1.1	1.1	0.9	2.8	18.5	1.1	0.9	0.9	14.7	1.3	5.6	1	1.2	0	0.9	0.9	0.9	0.9	1.3	1	3.4	1	1	1.1	6.7	0	1.3	0	0.9	0.9	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0.5	0	0.3	0	0	0	0	0	0.5	0	0	0	0	0.2	0	0.9	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0.3	0.1	0	0.7	0	0	0	6.8	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.9	34.5	14.7	16.6	16.3	4.2	2.8	18.5	5.6	6.7	0	0	0	0	0	0.6	1.6	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	39	0	0	0	0	1	0	0	0.3	1.4	0	0.1	0	0	0	Muller glia cells
DAPL1		ENSG00000163331	Death associated protein like 1	A0PJW8	2	158795317-158862781	Predicted intracellular proteins, Predicted membrane proteins	Apoptosis, Differentiation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3	Cell type enriched	Detected in many	5	Muller glia cells: 522.1	Group enriched	Detected in all	7	cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1	Not detected	Not detected							HPA046937, HPA058635	Enhanced		Approved	Nucleoplasm,Nuclear bodies,Microtubules						Nucleoplasm, Nuclear bodies, Microtubules		HPA046937: AB_2679870, HPA058635: AB_2732625	unprognostic (3.95e-5)	prognostic favorable (8.43e-4)	unprognostic (2.05e-1)	unprognostic (1.55e-1)	unprognostic (2.98e-1)	unprognostic (4.63e-2)		unprognostic (8.59e-2)	unprognostic (5.24e-2)	unprognostic (4.59e-2)	unprognostic (2.44e-1)	unprognostic (1.41e-1)	unprognostic (2.44e-3)	unprognostic (4.09e-2)	unprognostic (6.68e-2)	unprognostic (3.00e-2)	unprognostic (2.30e-3)	0.3	14.7	1.4	0.4	1.3	0	7.4	0.4	1	11.7	1	0.8	1.6	0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0	5.6	0.2	1.5	2.3	0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2	21.1	1.4	4	2.9	2.6	2.8	1.3	0.5	0	0	0	0.2	0	0	0.4	0	0	0.1	0	0.3	0.1	0	0.1	0	0	3.7	0	0	0	0.1	0	0.1	2.3	0	0	0	0	0.2	22.1	0	0	0.8	0	0.3	0	0	0.1	0	0	0.3	0.1	0	0.1	0	0.8	0	0	0.3	5.7	0	0	0	0.6	0	0.6	1.1	0	0.2	0.1	0	0.2	0	0	0	8.1	0	0	2.9	2.6	1.6	0.5	1.9	1	1.2	0.8	0.4	1	1.4	0.4	0.5	2.2	2.8	0.6	4	1.3	0.5	1.4	1.3	0.4	1	1.5	3.6	2.8	0.3	1.5	0.8	0	0	14.6	31.4	94.9	6.8	0	5.1	1.4	17	8.7	5.9	5.5	3.3	8	10.6	0.5	2.5	0	5.1	10.7	4.1	10.8	4.6	12.1	12.9	3.2	2.9	0.6	7.9	43.8	3.7	5.5	11.8	2.8	1.6	522.1	5.7	3.5	2.1	5.8	16.3	0	5.1	9.8	4.1	110.7	3.8	1.9	2.5	25.5	Muller glia cells
CLRN1	RP61, USH3, USH3A	ENSG00000163646	Clarin 1	P58418	3	150926163-150972999	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Hearing, Sensory transduction, Vision		Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	adrenal gland: 11.2;retina: 16.2	Cell type enriched	Detected in some	6	Muller glia cells: 150.4	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		plasmacytoid DC: 1.8	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	32	NTERA-2: 8.9																						unprognostic (1.00e-3)				unprognostic (1.26e-1)					unprognostic (5.54e-1)					unprognostic (9.68e-2)			0	11.2	0	0	0	0	0	0	0	0.1	0	0	0	3.2	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	16.2	0	0	0.1	0	1.6	0	2	0.1	0	0.7	0	0	0	0	0	0	0.1	0.2	1.8	0.7	0.1	0.1	0	0	0	0.1	0.1	0	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0.1	0.1	0.1	0	0	0	0	8.9	0	0.2	0	0.1	0.1	0	0	0.2	0.2	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0.7	0.1	0.1	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.8	0	0	0	0	0	0	0	0	0	150.4	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	Muller glia cells
SCRG1	SCRG-1	ENSG00000164106	Stimulator of chondrogenesis 1	O75711	4	173384701-173406380	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 33.4	Cell type enriched	Detected in many	4	Muller glia cells: 148.4	Cancer enriched	Detected in many	6	glioma: 35.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	13	HSkMC: 6.8;WM-115: 19.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012882	Approved				Secreted in brain							HPA012882: AB_1856635	unprognostic (1.09e-1)	unprognostic (1.83e-2)	unprognostic (2.60e-5)	unprognostic (2.58e-1)	unprognostic (3.22e-2)	unprognostic (7.51e-2)	unprognostic (3.58e-2)	unprognostic (1.14e-3)	unprognostic (2.08e-1)	unprognostic (2.25e-2)	unprognostic (2.19e-1)	unprognostic (1.49e-1)	unprognostic (3.95e-10)	unprognostic (4.86e-2)	unprognostic (2.21e-1)	unprognostic (4.34e-3)	unprognostic (8.74e-4)	5.8	3.1	19.2	2.6	18.6	2.2	2.3	6	30.6	2.1	2.9	15.9	4	2.5	2.5	7.7	2.3	2.1	5.1	3.6	19.9	12	1.5	1.4	1.5	1.5	24.9	12.9	1.6	1.8	1.2	1.1	1.6	20.5	6.4	2.7	0	3.4	11.6	1.9	2	2	15.6	33.4	2.4	2.8	16.3	22.5	0	1.5	0.3	1.3	4.1	1	1.4	1.3	4.4	1.8	1.6	1	0.4	0.1	0	0.9	0.3	0.4	0	0.2	0.1	0	0	0	0.2	0.1	0.1	0	0.2	0	0.2	0	0	0	0.1	0	0.2	0.4	0.1	0.8	0.2	0.2	6.8	0	0	0.1	0.2	0	0.1	0.1	0.6	0	0.2	0.1	0.3	0.2	0	0	0.1	0	0	0	0.2	0.2	0.2	0	0.2	0.1	0	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0	0.1	0.1	0.1	19.8	3.9	1.8	1.2	0.8	1.2	0.6	0.8	0.6	0.7	0.7	1.4	0.8	1	4.4	1.6	1.3	1.3	0.5	0.4	19.2	18.6	6	16.7	19.9	12	24.9	12.9	20.5	22.5	0	4	0.5	1	3.2	11.8	0.8	0	1.4	1.2	0	35.3	0.2	0	0.2	14.9	2	0	0	0	0.2	5.2	1.4	9.2	0	0.5	15.9	1.2	6.2	3.1	21.8	24.2	1.6	21.9	0	0	148.4	0.1	0	19.4	0	30.2	12.9	10.9	1.9	2.2	2.3	0.6	3.9	0.2	0.7	Muller glia cells
FABP7	B-FABP, BLBP	ENSG00000164434	Fatty acid binding protein 7	O15540	6	122779475-122784074	Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 62.7;breast: 26.8	Cell type enriched	Detected in some	5	Muller glia cells: 827.1	Group enriched	Detected in many	6	glioma: 139.3;renal cancer: 51.2	Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 3.1	Group enriched	Detected in many	5	granulocytes: 3.1;NK-cells: 1.1	Group enriched	Detected in some	8	AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3	Region enriched	Detected in all	6	olfactory region: 1471.1	Low region specificity	Detected in all			CAB025488, HPA028825, CAB058697	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Cytosol						Nucleoplasm	Golgi apparatus, Cytosol	CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130	prognostic favorable (2.49e-4)	unprognostic (1.56e-2)		unprognostic (2.53e-3)	unprognostic (5.80e-2)	unprognostic (2.29e-1)		unprognostic (1.14e-1)	unprognostic (7.11e-2)		unprognostic (2.09e-2)	unprognostic (3.42e-2)	prognostic unfavorable (1.65e-6)	unprognostic (9.83e-2)	unprognostic (1.30e-2)	unprognostic (2.50e-1)	unprognostic (8.66e-2)	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13	0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1	2.1	1.3	11.2	1.3	1.2	5.7	7	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0	1.1	0	1.1	1.4	0	0.4	0.2	3.1	0.3	1.1	0.4	0	0	0	38.7	0	0	0	1.4	0	0.3	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	0	0.1	0	0	10.5	0	0	0	0.4	0	23.3	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0	34.8	15.5	51.6	27.3	32	16.4	11.4	30.3	11.2	6.9	0	0	0	0.1	10.9	6.8	0.4	0	0	0	0	11.8	4.7	0	0	0	0.1	0	0	0	162.7	1.1	0	0	0	2.5	4.8	0	0	0	0	0	0	28.7	0	0	827.1	0	0	0	0.2	37.4	0	0.8	0	0	16.6	5.9	0	0	0	Muller glia cells
SLC39A2	ZIP2	ENSG00000165794	Solute carrier family 39 member 2	Q9NP94	14	20999255-21001871	Predicted membrane proteins	Ion transport, Transport, Zinc transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8	Cell type enriched	Detected in some	4	Muller glia cells: 21.3	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	67	HaCaT: 23.1	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA030489, HPA073231	Uncertain		Approved	Plasma membrane,Cytoplasmic bodies						Plasma membrane	Cytoplasmic bodies	HPA030489: AB_10601488, HPA073231: 	unprognostic (2.76e-2)	unprognostic (4.86e-2)	unprognostic (9.72e-2)	unprognostic (2.37e-1)	unprognostic (2.46e-1)	unprognostic (2.71e-1)	unprognostic (3.42e-1)	unprognostic (1.70e-1)	unprognostic (4.43e-1)	unprognostic (6.20e-3)	unprognostic (3.31e-1)	unprognostic (2.80e-1)	unprognostic (3.62e-2)	unprognostic (1.91e-1)	unprognostic (5.80e-2)	unprognostic (3.71e-1)	unprognostic (2.30e-3)	0.1	0.1	0.1	0	0.1	0	1.3	0.3	0.4	5.6	1.2	0	44.3	0	0.8	0	13	0.3	0.1	0.2	0.4	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.4	0.2	1	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0	0.1	0	1.3	0.1	6.1	3.3	1.2	9.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0.1	0	0	0	0	0.2	0	0	0	23.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0.1	0	0.3	0.2	0	0.2	0	0	0.2	0	0.1	0	0	0	0	0	0.3	0.3	0	0	0	0.1	0	0	0	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.4	0.4	0	0.2	0.1	0.2	0	0	0	0	1.5	0.7	0	0.4	0	0	0	0	2	0	0	0	0.1	0	0	0	0	0	0.4	3.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0	21.3	0.1	0	0	0	0.7	0	0	0	0	5.3	0.2	0	0.8	4.2	Muller glia cells
CMTM5	CKLFSF5, FLJ37521	ENSG00000166091	CKLF like MARVEL transmembrane domain containing 5	Q96DZ9	14	23376808-23379772	Predicted membrane proteins	Chemotaxis	Cytokine		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	blood: 19.4;brain: 67.3	Cell type enriched	Detected in some	6	Muller glia cells: 28.7	Group enriched	Detected in some	37	glioma: 8.4;melanoma: 3.4	Low region specificity	Detected in all			Group enriched	Detected in some	8	basophil: 7.6;neutrophil: 2.8	Lineage enriched	Detected in single	11	granulocytes: 7.6	Cell line enriched	Detected in some	6	HEL: 42.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052338	Enhanced		Approved	Golgi apparatus,Vesicles						Golgi apparatus, Vesicles		HPA052338: AB_2681793	unprognostic (2.73e-3)	unprognostic (1.51e-1)	unprognostic (5.24e-1)	unprognostic (2.43e-3)	unprognostic (2.63e-1)	unprognostic (6.40e-2)		unprognostic (8.34e-3)	unprognostic (1.78e-1)	unprognostic (2.27e-2)	unprognostic (8.40e-2)	unprognostic (6.24e-4)	unprognostic (3.03e-3)	unprognostic (1.97e-3)	unprognostic (1.17e-1)	unprognostic (1.93e-1)	unprognostic (1.11e-2)	1.7	1.8	14.1	1.3	19.4	6.6	1.3	4.8	55.4	2.6	1.9	47	0	1.3	1.6	1.6	2.1	1.7	2.5	5.8	19.6	12.1	1.1	1	1.7	1.1	26.9	10.3	1.7	1.1	0.9	0.1	1.5	18.4	1.9	1.6	0.6	3.1	4.2	1.4	1.5	2	1.7	67.3	1.9	1.1	1.1	12.7	0	1	0	1	1.3	0.7	0.1	0.7	7.6	0.4	0	0.3	19.4	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	42.7	0	0	0	0	7	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.1	7.6	0.4	0.2	0.1	0.2	0	0.1	0.1	0	0.2	0	0	0	2.8	0	0	0.7	0.3	19.4	14.1	19.4	4.8	24.8	19.6	12.1	26.9	10.3	18.4	12.7	0	0	0	0.1	0.9	0	3.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.3	0	0	0	0.1	0	0	0.6	1.2	0	0	0	5	0	0	28.7	0	0	0	0	1	0	3.4	0	0	0.1	0	0	0	0.1	Muller glia cells
CRABP1	CRABP, CRABP-I, CRABPI, RBP5	ENSG00000166426	Cellular retinoic acid binding protein 1	P29762	15	78340324-78348230	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 40.1;retina: 73.2;thyroid gland: 80.6	Cell type enriched	Detected in some	23	Muller glia cells: 4142.9	Cancer enhanced	Detected in many		ovarian cancer: 117.2	Low region specificity	Detected in all			Cell type enriched	Detected in single	13	myeloid DC: 1.2	Lineage enriched	Detected in single	13	dendritic cells: 1.2	Group enriched	Detected in some	8	AF22: 146.8;NTERA-2: 43.9	Group enriched	Detected in many	5	amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8	Low region specificity	Detected in many			HPA017203	Enhanced	Supported										HPA017203: AB_1846512	unprognostic (1.23e-1)	unprognostic (3.76e-3)	unprognostic (1.46e-1)	prognostic unfavorable (4.72e-4)	unprognostic (2.01e-1)	unprognostic (4.35e-2)		unprognostic (1.05e-1)	unprognostic (1.35e-1)	unprognostic (2.45e-2)	unprognostic (9.79e-2)	unprognostic (1.21e-1)	unprognostic (2.79e-2)	unprognostic (9.37e-2)	unprognostic (2.17e-1)	unprognostic (1.07e-1)	unprognostic (2.69e-1)	0.7	1.3	6.3	1.8	25.6	0.6	24.8	2.8	12.4	1.2	1.9	3.3	0.3	0.9	1.5	1.9	0.7	0.5	1.2	0.7	1.1	21.9	4.2	0.5	0.8	0.6	16.9	4.5	0.7	0.7	0.5	6.3	7	40.1	1	1.3	73.2	0.6	24.8	0.5	12.3	2.3	1.3	7.3	21.1	1.9	0.6	2.4	0.4	80.6	2.4	1	0.7	0.4	0	1.2	0	0	0	0	0	0	0	146.8	0	0	0	0	0	0	0	0	9	0.1	0	0.9	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	7.8	0	43.9	0.1	0.1	0	0	0	0	0.2	12.3	8.3	0	0	0	3.7	0.2	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	6.3	25.6	2.8	12.4	1.1	21.9	16.9	4.5	40.1	2.4	0	0	0	0	8.7	31.5	0	0	0	0	0	31.4	0.7	59.7	0	0	0	0.2	0	0	0.4	7.4	0.3	0	0	1.3	9.5	0	0	0	0	0	0	182.2	0	0	4142.9	0	0	0	0.5	73.8	0	0	0	1.5	2.3	1.1	0	0	0	Muller glia cells
TSC22D4	THG-1, TILZ2	ENSG00000166925	TSC22 domain family member 4	Q9Y3Q8	7	100463359-100479279	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 97.2	Cell type enriched	Detected in many	4	Muller glia cells: 493.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		NB-4: 60.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006757	Uncertain		Approved	Cytosol						Cytosol		HPA006757: AB_1080403	unprognostic (2.34e-2)	unprognostic (3.06e-2)	prognostic unfavorable (2.66e-4)	unprognostic (5.77e-2)	unprognostic (1.69e-1)	unprognostic (3.06e-1)	prognostic unfavorable (9.45e-4)	unprognostic (9.96e-2)	unprognostic (1.27e-1)	unprognostic (1.62e-2)	unprognostic (2.31e-2)	unprognostic (3.36e-1)	unprognostic (1.09e-1)	unprognostic (1.54e-2)	unprognostic (3.84e-2)	unprognostic (7.36e-2)	unprognostic (3.81e-3)	11.2	11.9	77.8	16.4	83.5	32.4	7.7	17.8	92.4	9.7	9.9	96.1	3.4	12.4	9.1	6.2	10.3	9.9	8	10.2	69.5	53.8	8.9	5.1	10.2	18.7	97.2	40.6	11.7	9.7	8.8	7.1	12.2	60.5	11.5	6.2	11.8	49.2	13	7.8	17.2	12.5	8	89.8	24	11.7	8	62.3	6.7	5.8	1.7	12.2	8.6	5.7	6.9	7.5	32.2	11.4	10.2	13.8	8.8	12.3	9.3	3.2	10.6	11.3	13.5	6	9.4	15.9	9.1	8.4	4.9	7.6	11.2	11.2	7.6	20.8	9.6	3.8	8.5	3.2	19.2	7.7	10	9.8	4.2	18.1	13.2	26.8	15.2	7.7	10.5	10.5	10.8	18.7	9	22.1	20.7	7.3	22.5	16.5	60.8	4.3	10.9	13.3	27.3	2.5	15.5	7.5	6.8	2.7	7.5	13	25	19.6	5.5	7	19.6	15.5	12.4	12.6	30.2	6.9	13	12.3	7.9	11.4	20.4	14.9	5	10.9	15.6	11.7	11.4	9.1	6.9	10	10.8	7.2	6.6	9.6	10	32.2	10.2	10.8	7.5	13.8	8.8	77.8	83.5	17.8	65.4	69.5	53.8	97.2	40.6	60.5	62.3	11.9	6.2	54.1	32.3	29.1	13.9	11.6	45.9	4	4.5	38.4	5.9	27.8	116	50.9	1.4	25.1	57.3	0	29.7	30.6	33.2	48.6	16.1	9.5	68	17.5	32.2	43.6	53.1	3.1	42.3	43.7	52.3	86.6	28.4	493	47.4	43.5	37.4	15.9	11.6	45.3	36	0.9	3.6	29.5	66.1	90.8	30.2	50.5	Muller glia cells
ENHO	C9orf165, UNQ470	ENSG00000168913	Energy homeostasis associated	Q6UWT2	9	34521040-34523041	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	4	brain: 79.6	Cell type enriched	Detected in many	5	Muller glia cells: 53.5	Cancer enhanced	Detected in many		glioma: 44.8	Low region specificity	Detected in all			Cell type enriched	Detected in some	7	myeloid DC: 19.4	Lineage enriched	Detected in many	7	dendritic cells: 19.4	Cell line enhanced	Detected in many		AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042575	Approved				Secreted to blood			4240000				HPA042575: AB_10794914	unprognostic (2.63e-2)	unprognostic (9.53e-3)	unprognostic (2.46e-1)	prognostic unfavorable (3.71e-4)	unprognostic (1.30e-1)	unprognostic (7.51e-2)	unprognostic (9.93e-2)	unprognostic (1.34e-2)	unprognostic (5.86e-2)	unprognostic (2.19e-2)	unprognostic (2.78e-4)	unprognostic (1.75e-1)	unprognostic (2.57e-3)	unprognostic (6.47e-2)	unprognostic (1.87e-1)	unprognostic (5.50e-2)	unprognostic (8.76e-2)	1.5	1.9	58	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0	3	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12	2	1.4	52	27.1	1.5	2.6	1.2	1	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0	1.4	0	1.4	1.5	0	0	19.4	0	2.5	2.7	0	0.4	0.1	1	5.3	13.4	0.1	0	0.3	0	0	2.1	2.2	0.5	0.2	2.2	3.7	0	4.3	0.2	6.1	0.4	0.4	0.3	5.9	0	0.1	1.2	0.2	0	3	0	0.1	0	0.2	0	0	4.3	0	1.9	0.5	0.3	0	0	18.5	1	3.7	0.1	0	0.3	0.5	0	9.4	8.9	0.7	4.1	0.4	0.7	0.3	1.7	0	0.4	2.1	0.1	0.1	1.1	1.3	0.1	0.5	0	3.1	0	0.1	0	0	2.5	0	0	0	0	19.4	0	0	0	0	2.7	0.7	1	0	0.4	58	59.3	15.5	37	36.3	37.5	52	27.1	13.7	13.4	0	0.3	0	2.5	2.5	4.3	0.4	0	0	0	0	2	0.1	0	0.7	0.7	0	0	0	0.2	0.2	1	10.2	0	2.6	2.6	4.8	1.7	1.3	0.3	2.7	0.3	3.2	1.7	1	0	53.5	0	0	0.4	0.3	2.8	0	0.1	0.5	5.9	2.8	0	0	0	0.5	Muller glia cells
PGM2	FLJ10983	ENSG00000169299	Phosphoglucomutase 2	Q96G03	4	37826633-37862937	Enzymes, Predicted intracellular proteins	Carbohydrate metabolism, Glucose metabolism	Isomerase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Muller glia cells: 345.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040676	Uncertain		Approved	Intermediate filaments					1900000	Intermediate filaments		HPA040676: AB_2677076	unprognostic (3.11e-2)	unprognostic (1.01e-2)	prognostic favorable (2.14e-5)	unprognostic (2.29e-1)	unprognostic (3.94e-1)	unprognostic (5.44e-2)	unprognostic (1.70e-2)	unprognostic (2.09e-3)	unprognostic (5.32e-2)	unprognostic (7.02e-2)	unprognostic (5.37e-2)	unprognostic (2.22e-2)	unprognostic (6.72e-3)	unprognostic (3.21e-2)	unprognostic (1.88e-1)	unprognostic (9.97e-2)	unprognostic (1.02e-1)	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15	7.6	41.3	7	11	8.3	7.1	4	11.1	13.3	7.5	13.2	4.4	5.7	10	9	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11	5	2.4	17.7	8.6	12.2	6.9	13.4	9	9	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4	5	16.3	13.2	8	3.4	7	7.2	7.7	5.9	9.8	5.7	7.1	4	4.4	5.7	10.4	3.9	0	8	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0	26.6	5	13	0.8	25.5	7.9	0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5	52.3	9	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9	Muller glia cells
GPR37L1	ETBR-LP-2	ENSG00000170075	G protein-coupled receptor 37 like 1	O60883	1	202122858-202133592	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	brain: 44.0	Cell type enriched	Detected in some	11	Muller glia cells: 51.7	Cancer enriched	Detected in some	57	glioma: 36.2	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	HaCaT: 2.9;MCF7: 3.3;T-47d: 9.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064454	Enhanced											HPA064454: AB_2685268	unprognostic (2.12e-2)	unprognostic (1.83e-1)	unprognostic (2.96e-1)	unprognostic (1.61e-3)	unprognostic (4.52e-1)	unprognostic (8.20e-2)	unprognostic (2.26e-4)	unprognostic (5.83e-2)	unprognostic (3.46e-3)	unprognostic (2.07e-1)	unprognostic (1.83e-1)	unprognostic (3.28e-2)	unprognostic (4.86e-3)	unprognostic (1.14e-1)	unprognostic (4.58e-2)	unprognostic (1.18e-3)	unprognostic (3.49e-1)	1.6	2	20.5	1.6	25.2	1.9	1.6	13.2	44	2	2.4	33.4	0	1.9	1.8	1.8	1.7	1.8	1.7	1.6	22.3	12.6	1.5	1.6	1.6	1.5	17.7	22.1	1.7	1.5	1.5	0.4	1.6	23.8	1.7	1.9	0.9	1.9	2.3	1.7	1.8	2.1	1.7	11.1	1.6	1.6	1.9	15.7	0	1.8	0	1.5	1.6	0.2	0.9	0.9	1.8	0.9	0.6	1.4	0.2	0.1	0.6	0	0	0	0	0.3	0	0.2	0	0	0.2	0.6	0	0.2	0	0.1	2.9	0	0	0.4	0.1	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	3.3	0	0.1	0.2	0.1	0	0	0	0	0	0.2	0.1	0.5	0.1	1.2	0	0.1	9	0.1	0	0	0	0.1	0	0.1	0	0.1	0.1	0	0	1	0.8	0.7	0.5	0.9	0.7	0.6	0.3	0.2	0.6	0.9	0.7	0.5	1.8	0.6	0.4	0.9	1.4	0.2	20.5	25.2	13.2	39.3	22.3	12.6	17.7	22.1	23.8	15.7	0	0	0	0.5	0.3	1.1	0.8	0	0	2.3	0	3.9	0	0	2.5	3.5	0	1	0	1.1	0.8	0.1	0.7	0	0	0	0	0	0	0	0.5	0.9	0	0	0	0.5	51.7	1.5	2.9	1.8	0	4.7	0	0.2	0	0.1	0.1	0.6	0	0.4	0.8	Muller glia cells
GPR37	EDNRBL, hET(B)R-LP, PAELR	ENSG00000170775	G protein-coupled receptor 37	O15354	7	124745997-124765627	G-protein coupled receptors, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 62.4	Cell type enriched	Detected in many	36	Muller glia cells: 779.4	Cancer enhanced	Detected in many		glioma: 19.2	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042903, HPA068009	Approved		Approved	Nuclear membrane,Cytosol		No	No		48000	Nuclear membrane, Cytosol		HPA042903: AB_2678219, HPA068009: AB_2685940	unprognostic (2.47e-1)	unprognostic (2.57e-1)	unprognostic (2.46e-1)	unprognostic (3.30e-2)	unprognostic (7.29e-2)	unprognostic (1.06e-1)	unprognostic (2.45e-1)	prognostic unfavorable (6.00e-5)	unprognostic (6.19e-2)	prognostic favorable (7.26e-4)	unprognostic (6.54e-2)	unprognostic (2.58e-1)	unprognostic (3.16e-2)	unprognostic (6.12e-3)	unprognostic (2.10e-1)	unprognostic (1.88e-1)	unprognostic (1.71e-4)	1.6	1	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0	1	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1	3	0.8	0.3	10	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3	49.4	4.3	1.2	15.5	26.5	0	0.9	0	0.9	1.2	0.5	0	0	0	0	0	0	0	0.1	1.7	9.4	0	0	0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0	0	22	0.3	0.2	2.8	0	0.5	0.4	1.2	0.1	5.9	0	2.8	0	0.4	0	9.8	0	0.1	0	4.5	0	0	4.3	0	0.5	0	0	1.4	0	4.5	0	0	0	0	0.1	2.2	3.3	0	8.5	3.2	10.6	2.2	0	15.3	2	0.7	0	0	1.3	0	0	1	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5	0	0	0	0.3	4	21.7	0.4	2.5	0	0	1.8	5.9	7.1	0	4.3	0.2	0.5	0	0	0.5	15.1	2.7	2.1	0	21.5	1	17.5	0	0	0.3	0.9	2.6	0	3.3	1	0.4	779.4	0.4	0	0.7	0	12.5	0	0.9	0.6	0.7	8.9	2.5	0	0	0.1	Muller glia cells
TRH		ENSG00000170893	Thyrotropin releasing hormone	P20396	3	129974305-129977938	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5	Cell type enriched	Detected in some	31	Muller glia cells: 222.3	Cancer enhanced	Detected in some		breast cancer: 13.3;endometrial cancer: 10.2	Group enriched	Detected in many	14	hypothalamus: 33.9;pons and medulla: 33.8	Group enriched	Detected in some	11	intermediate monocyte: 1.1;non-classical monocyte: 1.0	Lineage enriched	Detected in single	12	monocytes: 1.1	Cell line enhanced	Detected in some		REH: 2.6;SuSa: 4.0;T-47d: 2.4	Group enriched	Detected in many	5	hypothalamus: 204.6;olfactory region: 182.2	Low region specificity	Detected in many			HPA035596	Enhanced				Secreted in other tissues							HPA035596: AB_2674695	unprognostic (1.22e-1)	unprognostic (8.94e-2)		unprognostic (5.82e-3)	unprognostic (5.24e-2)	unprognostic (2.82e-1)		unprognostic (1.11e-1)	unprognostic (1.84e-1)	unprognostic (4.44e-2)	unprognostic (3.86e-2)	unprognostic (1.50e-1)	unprognostic (1.71e-2)	unprognostic (2.85e-1)	unprognostic (1.95e-1)	unprognostic (2.57e-2)	unprognostic (2.82e-2)	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0	0.8	0.1	0	0.1	0.1	0.3	0	0	0	1.1	0	0	0	0.1	0	0.7	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0.3	0.2	0	0	2.6	0	0	0	0	0.4	0.1	0.3	0	0	4	2.4	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0.4	2.4	0.3	1.7	2	33.9	0.4	0.8	33.8	0	0	0	0	0.5	0.7	6.8	0.8	0	0	0	0	0	0	0	0	1.3	0.3	0	0	0	0	0.4	0	0	0	0.1	4.8	0	0	0	1.5	0	0	0	0	0	222.3	0	0	0	0	7.1	0	0.4	0.4	0.4	0.1	0.1	0	0	0.5	Muller glia cells
COL24A1		ENSG00000171502	Collagen type XXIV alpha 1 chain	Q17RW2	1	85729233-86156943	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 18.0	Cell type enriched	Detected in some	6	Muller glia cells: 59.8	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Cell type enriched	Detected in single	10	plasmacytoid DC: 6.2	Lineage enriched	Detected in single	10	dendritic cells: 6.2	Cell line enhanced	Detected in some		ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2	Low region specificity	Detected in some												Secreted to extracellular matrix				12000				unprognostic (3.00e-1)	unprognostic (6.19e-2)	unprognostic (2.21e-2)	unprognostic (6.76e-3)	unprognostic (1.82e-3)	unprognostic (2.45e-2)	unprognostic (2.44e-5)	unprognostic (1.37e-1)	unprognostic (4.08e-2)	unprognostic (6.59e-2)	unprognostic (3.89e-2)	unprognostic (1.46e-1)	unprognostic (3.48e-6)	unprognostic (2.79e-5)	unprognostic (5.07e-1)	unprognostic (1.19e-1)	unprognostic (9.90e-2)	1.1	0.4	6.2	3.4	7.1	2.3	1.1	1.7	18	7	9.5	0.3	0	4.1	3.6	2.4	2.2	0.6	4.4	4.1	12.1	1.2	1.5	0.3	1.7	1	1.1	5.2	6.9	0.3	0.2	2	0.3	1.7	2.3	2.4	2.4	1.2	4.3	1.4	1.6	3.7	2.8	1	0.8	3.4	1.9	2.9	0	0.8	2.6	0.8	8.3	4.9	0	6.2	0	0.1	0.6	0	0	0	0	1.5	0	3.4	0.6	0	0.6	0.1	0.2	0.5	0	0	0	0.2	0.1	0.4	0	0.9	0	1.4	0	0.8	0	1	0.1	0.1	0	0	3.2	0	0.2	0	0.1	0	0	0	6	0.9	0	0	0.2	3.1	0	0	0	4.4	0.5	0.6	1.1	0.1	0	0	0.2	0.5	4.6	0	0.9	0	2	0.2	0	0	11.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	6.2	0	0	6.2	7.1	1.7	18	12.1	1.2	1.1	5.2	1.7	2.9	0	1.1	1.9	0	0.3	2.2	1.6	0	2.7	0	5.2	0	0	0	0	0	0	0	0	0	0	1	0	1.1	0	1.8	0	0	0	0	0	0.9	0.3	10.1	0	0	59.8	0	0	0.7	0	1.1	0	0	1.1	0.4	0.1	0	0	0	0	Muller glia cells
PRIMA1	PRIMA	ENSG00000175785	Proline rich membrane anchor 1	Q86XR5	14	93718298-93788481	Predicted membrane proteins	Neurotransmitter degradation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		intestine: 26.2	Cell type enriched	Detected in some	11	Muller glia cells: 33.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5	Region enhanced	Detected in many		basal ganglia: 16.2	Low region specificity	Detected in all			HPA046671, HPA060047	Approved		Approved	Nucleoli,Plasma membrane,Cytosol						Plasma membrane	Nucleoli, Cytosol	HPA046671: AB_2679744, HPA060047: AB_2684194	unprognostic (3.60e-2)	unprognostic (1.97e-1)	unprognostic (7.54e-2)	prognostic unfavorable (6.99e-5)	unprognostic (1.03e-2)	unprognostic (3.73e-2)	unprognostic (1.07e-1)	unprognostic (5.81e-2)	unprognostic (2.93e-1)	unprognostic (1.05e-1)	unprognostic (8.94e-2)	unprognostic (6.61e-3)	prognostic unfavorable (2.62e-7)	unprognostic (2.33e-2)	unprognostic (2.67e-1)	unprognostic (7.94e-4)	unprognostic (4.57e-3)	4.6	6	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1	0.7	20.2	4	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0	1.3	0.9	4.4	4.7	7.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.3	0	7.5	0	0	0.2	0.4	0	0	4.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.7	0	0	3	0	0	0	0	0.3	0	0	13.2	7.5	0.4	0	0	0.5	1.5	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4	15.5	14.7	0	0	0	1	0.5	0.5	1.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.5	0.5	0	0	0.1	0	0	3.1	0	0.4	2.6	0	0	0	0	33.7	0.1	0	0	0	0.2	0	0.1	0.1	0.2	0.3	0	0	0	0.1	Muller glia cells
KCNA2	HK4, Kv1.2	ENSG00000177301	Potassium voltage-gated channel subfamily A member 2	P16389	1	110519837-110631474	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 28.0	Cell type enriched	Detected in some	5	Muller glia cells: 24.2	Cancer enhanced	Detected in some		glioma: 1.2	Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 4.1	Lineage enriched	Detected in single	8	T-cells: 4.1	Cell line enhanced	Detected in some		Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB001976	Enhanced											CAB001976: 	unprognostic (1.84e-2)	unprognostic (9.70e-3)	unprognostic (1.97e-1)	unprognostic (2.98e-1)	unprognostic (7.17e-3)	unprognostic (6.68e-3)		unprognostic (5.05e-3)	unprognostic (2.02e-1)	unprognostic (1.29e-1)	unprognostic (4.50e-3)	unprognostic (3.08e-3)	unprognostic (2.93e-4)	unprognostic (2.15e-1)	unprognostic (3.55e-1)	unprognostic (6.41e-2)	unprognostic (2.83e-1)	3.2	1.4	7.1	2.2	13.1	0.8	1.2	17.2	28	1.2	1.6	3.1	0	1.4	1	1.3	1.7	1.1	1.6	1.6	7.2	6.1	0.9	0.9	1	1.9	7.2	14.5	1.1	1.9	0.8	1.4	0.7	21.1	1.8	2	1.4	1.8	2.4	2.1	1.6	1.6	1.6	2.8	1.3	1.3	2.5	3.8	0.3	5.3	0	3.5	1.4	0.5	0.5	0	0	0	0	4.1	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	10.9	0	0	0	0	1	0	0	0.5	0	1.4	0	0	2.8	0	0	0	1.2	0.6	0	0	0	0.1	2.4	0	0	3.6	5.4	0.2	0.1	0	2.9	0	0	0	0.4	0	0.3	0.5	1.8	1.3	0	0	0.7	0.3	0	0	0	0	4.1	0.1	7.1	13.1	17.2	26.3	7.2	6.1	7.2	14.5	21.1	3.8	0	0	0	0	0	3.7	0.8	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0.8	0	0	0	0	0	24.2	0	0	4.9	0	2.9	0	0.5	0	1.4	0	0	0	0	0	Muller glia cells
KCNJ10	Kir1.2, Kir4.1	ENSG00000177807	Potassium voltage-gated channel subfamily J member 10	P78508	1	159998651-160070483	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Deafness, Disease mutation, Epilepsy, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 74.1;kidney: 28.1	Cell type enriched	Detected in some	8	Muller glia cells: 83.5	Cancer enriched	Detected in some	6	glioma: 27.4	Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 2.5	Group enriched	Detected in many	6	NK-cells: 1.7;T-cells: 2.5	Cell line enhanced	Detected in some		Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA078302	Enhanced											HPA078302: AB_2732378	unprognostic (2.64e-2)	unprognostic (3.54e-3)	unprognostic (6.19e-2)	unprognostic (1.33e-1)	unprognostic (2.84e-1)	unprognostic (6.98e-4)	unprognostic (1.96e-1)	unprognostic (7.13e-2)	unprognostic (3.43e-1)	unprognostic (1.28e-3)	unprognostic (5.80e-4)	unprognostic (9.52e-2)	unprognostic (2.09e-2)	unprognostic (2.08e-2)	unprognostic (1.41e-1)	unprognostic (3.77e-1)	unprognostic (6.70e-3)	1.4	1.5	23.6	3	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2	1.8	25.5	0	1.5	0	2.9	1.5	0.1	0	0	0	0.3	1.7	2.5	0.2	0	0	0.1	0	0	0.4	0.3	0	0	0.3	0.3	0	0.2	1.7	0.2	0	1.1	0.4	0.3	0	0.2	0	0.2	0.1	0.1	11.7	0	0	0.1	0	0	0	0.2	0.1	0	0.9	0	0.3	0	0	0	0	0.2	0.2	0.6	0	2.2	0.1	0	0	0.2	0.4	0	0.3	3.7	1	0.1	0.5	0.1	0.1	0.3	0.9	0	3.8	1.7	0	0.2	0.2	1.8	0	0.3	0	0.4	0.3	0	0	0.1	0.5	0	0	0	1.8	0	1.7	0.3	0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5	0	0	0	0	0	0.6	0.4	0	0	0	3.5	3.9	0	10	0	0.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	6.4	1	0	0	0	0	0	83.5	0	0	0	0.2	2	0	0	0.2	0.1	0	0	0	0	0	Muller glia cells
NEUROG2	Atoh4, bHLHa8, Math4A, ngn-2, NGN2	ENSG00000178403	Neurogenin 2	Q9H2A3	4	112513516-112516172	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 4.1;testis: 5.1	Cell type enriched	Detected in some	5	Muller glia cells: 8.2	Cancer enhanced	Detected in single		endometrial cancer: 0.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	SH-SY5Y: 68.9	Low region specificity	Detected in some			Region enriched	Detected in some	18	hippocampal formation: 17.3	CAB012342	Uncertain											CAB012342: 	unprognostic (1.09e-1)	unprognostic (2.52e-2)	unprognostic (7.51e-2)	unprognostic (4.10e-1)	unprognostic (1.62e-1)	unprognostic (7.75e-2)		unprognostic (1.04e-1)	unprognostic (1.13e-3)						unprognostic (1.02e-1)	unprognostic (3.30e-1)		0.4	0.1	3	0	3.6	0.1	1.2	4.1	1.6	0	0.1	0.5	0	0	0.1	0	0	0.1	0	0.4	3.9	0.1	0	0.1	0.1	0.2	0	0	0.1	0	0	0	0	0.9	0	0	0.5	0.2	0.1	0.2	0.1	0.6	0	0.1	0	0	5.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.3	0	0	0	0.1	0	0	0	0	0.8	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	68.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3.6	4.1	0.8	3.9	0.1	0	0	0.9	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	8.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Muller glia cells
RRH	peropsin	ENSG00000180245	Retinal pigment epithelium-derived rhodopsin homolog	O14718	4	109827994-109844604	G-protein coupled receptors, Predicted membrane proteins	Sensory transduction	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	retina: 66.3	Cell type enriched	Detected in single	53	Muller glia cells: 36.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		T-reg: 1.3	Lineage enriched	Detected in single	7	T-cells: 1.3	Cell line enhanced	Detected in some		hTCEpi: 4.1;U-266/84: 4.7	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (1.59e-1)	unprognostic (2.47e-2)	unprognostic (4.94e-2)	unprognostic (1.96e-2)	unprognostic (1.48e-1)	unprognostic (5.25e-2)	unprognostic (7.56e-2)	unprognostic (8.47e-2)	unprognostic (2.33e-1)	unprognostic (1.86e-2)	unprognostic (2.03e-2)	unprognostic (1.62e-3)	unprognostic (4.65e-1)	unprognostic (4.38e-3)	unprognostic (1.22e-1)	unprognostic (2.27e-1)	unprognostic (3.18e-2)	0.4	1.4	1.3	0.5	1.2	0.3	2.1	3.7	1.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.4	0.4	1.2	1.2	1.9	1	0.4	0.5	1.2	0.6	0.6	0.5	0.7	0.5	0.4	0.4	0.9	0.8	66.3	0.5	0.7	0.7	2.3	0.4	0.4	0.8	0.5	0.4	0.7	0.4	0.4	0.9	0.4	0.4	0.4	0.4	0.1	0	0	0	0	1.3	0.1	0	0.2	0.9	0.7	0	0.1	0	0.2	0.7	0.1	0.1	0.2	0.3	0.9	0.8	0.3	0	0	2.2	0.1	0.2	1	0.9	0.1	0	0.3	0.1	1.5	0	0	4.1	0	0.3	0.4	0.2	0.7	1	0.3	0.7	0.1	1.2	1.6	0.5	0.7	0.2	1	0.2	0.6	2.1	0.2	1.1	0.3	0	0.4	0.1	0.5	0.8	0.5	0.4	0	0.3	0.5	0.1	0.6	4.7	0	0.3	0.5	1.1	0	0	0	0.2	0	0.4	0.1	0.3	0.2	0	0.1	0.1	0	0	0	0	0	1.3	0.1	1.3	1.2	3.7	1.4	1.2	1.2	1.2	0.6	0.4	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36	0	0	0	0	0.7	0	0	0.3	0	0	0	0	0	0	Muller glia cells
SOX2		ENSG00000181449	SRY-box 2	P48431	3	181711924-181714436	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cancer-related genes, Disease mutation, Microphthalmia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 80.1	Cell type enriched	Detected in some	9	Muller glia cells: 455.6	Cancer enhanced	Detected in many		glioma: 136.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045725, HPA062851, HPA071379, CAB079745	Enhanced	Supported	Enhanced	Nucleoplasm						Nucleoplasm		CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: 	unprognostic (1.80e-2)	unprognostic (3.18e-3)	unprognostic (5.69e-2)	unprognostic (6.96e-2)	unprognostic (2.74e-3)	unprognostic (1.60e-1)	unprognostic (1.79e-2)	unprognostic (4.48e-3)	unprognostic (1.71e-1)	unprognostic (4.38e-3)	unprognostic (1.83e-1)	unprognostic (7.68e-2)	unprognostic (3.81e-9)	unprognostic (1.12e-1)	unprognostic (2.12e-1)	unprognostic (1.26e-1)	unprognostic (1.12e-2)	1.8	2.5	30.3	2	25.8	1.5	1.6	13.9	80.1	1.8	2.3	24.3	0	2	1.5	1.8	15.9	5	1.8	1.7	36	19.2	1.5	1.5	3.4	1.5	19.4	18.5	1.7	1.6	1.5	5.8	1.5	18.6	3.9	2	1	6.3	1.9	1.6	1.8	2.3	1.7	18.4	1.6	9.7	3	22.4	0	1.5	2.1	6.9	2.3	1.7	0	0	0	0	0	0.3	0	0	2.2	68.9	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0	0.1	29.3	0.7	0	0	4.4	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.1	0	0	56.2	2.9	0.1	0	0.1	0	7.6	0.1	0.1	0.3	0	0	0	11.9	0.4	0	0	0	1	0	12.9	0	0	0	0	0	8.6	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	30.3	25.8	13.9	20	36	19.2	19.4	18.5	18.6	22.4	0	5.9	0	41.2	0.2	3.5	0.4	0	52.2	38.7	3.5	0	0	0	0	0.7	0	0	0	0	0	0.2	4.9	1.1	0	0.1	0	0	1.3	0	0	0.6	0.2	3.3	0	0	455.6	0	0	0	0	8.2	0	0.1	1.5	0.2	0.4	0.2	0	0	7	Muller glia cells
POU3F2	BRN2, OCT7, OTF7, POUF3	ENSG00000184486	POU class 3 homeobox 2	P20265	6	98834592-98839470	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	brain: 28.0	Cell type enriched	Detected in some	8	Muller glia cells: 12.3	Cancer enriched	Detected in some	11	glioma: 16.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 52.2;SK-MEL-30: 7.1;U-251 MG: 15.9;WM-115: 13.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047081, HPA056261		Approved	Supported	Nucleoplasm						Nucleoplasm		HPA047081: , HPA056261: AB_2683081	unprognostic (5.94e-4)	unprognostic (7.80e-2)	unprognostic (3.07e-3)	unprognostic (1.83e-1)	unprognostic (3.57e-1)	unprognostic (1.38e-1)	unprognostic (1.17e-3)	unprognostic (1.84e-1)	unprognostic (1.16e-1)	unprognostic (1.60e-1)	unprognostic (1.63e-3)	unprognostic (4.77e-1)	unprognostic (9.38e-11)	unprognostic (4.77e-2)	unprognostic (2.84e-2)	unprognostic (8.47e-3)	unprognostic (4.04e-1)	0.9	1	9	0.9	10.8	0.9	0.9	3.4	28	0.9	0.9	10.3	0	0.9	0.9	0.9	0.9	0.9	0.9	0.9	9.8	7.1	0.9	0.9	0.9	0.9	10.7	6.8	0.9	0.9	0.9	0	0.9	9.7	0.9	0.9	0	0.9	0.9	0.9	1	0.9	0.9	8.4	0.9	0.9	1.2	9	0	0.9	0	0.9	0.9	0	0	0	0	0	0.6	0	0	0	0	52.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	3.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0.6	1.9	0	0	0	0.4	0	0.2	0	2.2	1.7	0.4	0	0	0	2.9	1.5	0	0	7.1	0	0.4	0	0	0.3	0	0.1	15.9	0	0	0	0	0	13.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	9	10.8	3.4	12.5	9.8	7.1	10.7	6.8	9.7	9	0	0	0	0.2	0.1	0.1	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	12.3	0	0	0	0	0	0	0.1	0.2	1.4	0.1	0	0	0	0.2	Muller glia cells
SLITRK2	CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257	ENSG00000185985	SLIT and NTRK like family member 2	Q9H156, O96002	X	145817832-145829856	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.1	Cell type enriched	Detected in some	9	Muller glia cells: 226.8	Cancer enhanced	Detected in some		glioma: 5.4	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	35	HAP1: 21.7	Low region specificity	Detected in all			Low region specificity	Detected in all												26000				unprognostic (2.13e-1)	unprognostic (1.12e-1)	unprognostic (2.73e-3)	unprognostic (6.79e-6)	unprognostic (3.39e-1)	unprognostic (1.68e-1)	unprognostic (2.89e-4)	unprognostic (6.23e-2)	unprognostic (3.60e-1)	unprognostic (1.29e-1)	unprognostic (1.50e-2)	unprognostic (3.53e-2)	unprognostic (4.13e-8)	unprognostic (3.12e-3)	unprognostic (2.18e-2)	unprognostic (1.14e-1)	unprognostic (1.14e-2)	1.6	1.5	12.8	1.2	16.4	0.9	1.2	4.3	25.1	1.7	1.2	13.3	0	1.1	1.1	1.1	1.1	4.9	1.1	1.6	12.1	3.5	1.4	1	2.2	1.6	11.3	9.2	1.1	1.8	0.9	1.1	0.9	10.4	1.4	1.4	5.6	1.3	8.5	1.2	3.9	1.3	1.5	12.6	7.4	1	1.2	11.5	0	1.1	0	0.9	1.3	1.1	0.3	0.3	1.5	0.3	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0.1	0	0.2	0	0.1	0	0	0	0.5	0.1	0	0	0	0.1	0.6	0	0.5	0	0	0	0	0	0	1.5	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0	0.3	0.3	0.2	0.6	0.4	0.3	0.3	0.2	0	12.8	16.4	4.3	14.6	12.1	3.5	11.3	9.2	10.4	11.5	0	0	0	0	1	4.7	0.8	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0.4	0.1	0	0	0	6.4	1.7	1.8	0	0	0	0	25.3	0	0	226.8	0	0	0	0	9.5	0	0.5	0	0	1.3	0	0	0	0	Muller glia cells
FAM69C	C18orf51	ENSG00000187773	Family with sequence similarity 69 member C	Q0P6D2	18	74434099-74457944	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.1;heart muscle: 10.8	Cell type enriched	Detected in some	5	Muller glia cells: 197.8	Group enriched	Detected in some	18	glioma: 11.1;melanoma: 6.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	SK-MEL-30: 11.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA048928	Enhanced											HPA048928: AB_2680560	unprognostic (6.35e-2)	unprognostic (1.13e-2)	unprognostic (8.09e-2)	unprognostic (3.32e-2)	unprognostic (4.08e-2)	unprognostic (3.19e-1)	unprognostic (1.43e-2)	unprognostic (1.10e-1)	unprognostic (3.31e-1)	unprognostic (8.97e-2)	unprognostic (2.43e-1)	unprognostic (4.10e-2)	unprognostic (1.91e-4)	unprognostic (2.16e-1)	unprognostic (6.73e-2)	unprognostic (3.23e-2)	unprognostic (4.40e-3)	1.1	0.9	13.8	0.7	20.5	0.6	1.1	3.5	29.1	3.4	1	9.5	0	0.7	0.9	0.8	0.8	1	1.3	10.8	11	9	0.8	1.1	0.6	0.7	15.5	5.2	0.7	0.9	0.8	0.1	0.9	9.9	1.1	0.9	3.7	0.9	1.7	2.3	7	0.9	0.9	5.3	0.8	3	7.3	18.8	0	0.8	0	0.7	0.7	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	11	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	13.8	20.5	3.5	10.3	11	9	15.5	5.2	9.9	18.8	0	0	0	0	1.1	1	18.7	0	0	0	0	0	0	0	0.1	3.5	0.1	0	0	1.2	0	0.2	0.1	0	0	0.4	38.1	0	2.5	0.8	2	0	0	30.4	0	0	197.8	0.8	0	0	0	3.7	12.9	1.4	0.6	0	0.1	0	0	0	0	Muller glia cells
RYR1	CCO, MHS, MHS1, PPP1R137, RYR	ENSG00000196218	Ryanodine receptor 1	P21817	19	38433699-38587564	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	skeletal muscle: 231.0	Cell type enriched	Detected in many	5	Muller glia cells: 46.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	6	intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3	Group enriched	Detected in many	7	dendritic cells: 5.3;monocytes: 6.3	Cell line enhanced	Detected in some		A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6	Low region specificity	Detected in some							HPA056416	Enhanced		Approved	Golgi apparatus,Vesicles,Cytosol						Golgi apparatus, Vesicles	Cytosol	HPA056416: AB_2683121	unprognostic (2.22e-3)	unprognostic (1.91e-3)	unprognostic (9.59e-2)	unprognostic (5.34e-4)	unprognostic (2.50e-1)	unprognostic (6.00e-2)	unprognostic (2.11e-1)	unprognostic (1.06e-1)	unprognostic (1.18e-1)	unprognostic (3.20e-3)	unprognostic (3.52e-1)	unprognostic (2.35e-1)	unprognostic (1.07e-5)	unprognostic (1.13e-2)	unprognostic (8.10e-2)	unprognostic (6.62e-3)	unprognostic (1.34e-1)	5.3	0.7	3	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0	0.4	0.4	6.7	3	0.6	0.5	0.4	1.8	4	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0	0.6	0.6	0	5.7	0	0	0	0	1.4	0	0	0	0	2	0.3	0.3	4.8	0	0	14	0.2	0	0	0	0.3	1	0	0	0	0	0.4	1.3	5.7	0	0	0	0	0	0.8	0	0	0.1	0	0	0.4	0.7	0	0	11.5	1.1	0.6	0	0	1.1	22.8	0	0	0.4	0.5	4.3	0	0	9.6	0.2	0	0.3	1	0.3	0.1	0	0	0	0.6	0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0	0	0.1	0	6.3	0	0.6	0.6	3	1.9	2.7	1.7	1.8	4	1.5	1.3	1.9	1.9	0	0.6	0	3.4	10.1	4.1	3.4	0	0	0	0	2	0.1	5	0.1	5.2	0	0	0	0	0.2	0.3	0.6	0	0	7.1	1.6	0	0.6	1.9	4.7	2.8	4.5	0	0	0	46	0	0	1.8	0	1.5	0	0.3	5.5	6.9	4.1	0.2	0	0	0.1	Muller glia cells
HES5	bHLHb38	ENSG00000197921	Hes family bHLH transcription factor 5	Q5TA89	1	2528745-2530245	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 16.7	Cell type enriched	Detected in some	22	Muller glia cells: 105.2	Cancer enhanced	Detected in some		glioma: 3.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA065458, HPA076164	Enhanced		Approved	Nucleoplasm,Nuclear speckles,Cytosol		No				Nucleoplasm	Nuclear speckles, Cytosol	HPA065458: AB_2685492, HPA076164: AB_2732303	unprognostic (2.04e-3)	unprognostic (2.83e-2)	unprognostic (4.26e-2)	unprognostic (2.75e-3)	unprognostic (5.26e-3)	unprognostic (1.60e-4)	unprognostic (1.76e-4)	unprognostic (1.60e-1)	unprognostic (5.30e-2)	unprognostic (9.51e-2)	unprognostic (1.16e-1)	unprognostic (4.67e-1)	unprognostic (9.95e-4)	unprognostic (1.14e-3)	unprognostic (1.45e-1)	unprognostic (3.89e-2)	unprognostic (1.72e-1)	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1	1	1.4	1.1	4.1	15.8	1	0.9	1	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1	1.2	2	1.9	0	1.1	1.9	1.4	1.7	0.6	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0.1	0	0.1	0	0	0.1	0	0.2	0	0	5.1	1.1	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.9	0.1	0	0	0	0	0	1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9	0	0	0	0.2	0.1	2	1.1	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0.6	0	0	0	3.2	0	0	0	0	0	0	0	0	3	105.2	0	3.5	0	0	4.8	0	0.7	0	0	1.3	0	0	1.1	0.1	Muller glia cells
HEPN1		ENSG00000221932	Hepatocellular carcinoma, down-regulated 1	Q6WQI6	11	124919244-124920677	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	5	brain: 43.3	Cell type enriched	Detected in some	10	Muller glia cells: 23.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	240	Hep G2: 34.3									HPA043768, HPA063054	Uncertain		Approved	Golgi apparatus		Yes				Golgi apparatus		HPA043768: AB_2678662, HPA063054: AB_2684932																		8.4	0.5	22	0.4	20.4	0.3	0.3	4.2	43.3	0.3	0.4			0.3	0.4	0.3	0.4	0.3	0.3	0.5	17.9	11	0.4	4.5	0.3	0.5	19.3		0.4	0.3	0.3	0	0.3		0.3	0.3		0.5	0.3	0.5	0.3	0.5	0.3	19.4	0.3	0.4	0.4			0.3		0.3	0.3	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	2.4	0	0	0	0.6	0	0.4	0.6	0	0	0	0	23.5	0	0	1.1	0	1.4	0	0	1.9	0.4	0	0	0	0	0	Muller glia cells
SPON1	f-spondin, KIAA0762	ENSG00000262655	Spondin 1	Q9HCB6	11	13962689-14267884	Plasma proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 40.2	Cell type enriched	Detected in many	5	Muller glia cells: 163.5	Cancer enhanced	Detected in all		ovarian cancer: 199.1					Cell type enriched	Detected in some	5	MAIT T-cell: 7.3	Lineage enriched	Detected in single	74	T-cells: 7.3	Group enriched	Detected in some	35	EFO-21: 42.0;RPTEC TERT1: 118.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038584, HPA077546	Uncertain		Approved	Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge	Secreted to blood	Yes	No	11500000	27000000	Nucleoli, Microtubule ends	Nucleoplasm, Actin filaments, Cytokinetic bridge	HPA038584: AB_10697394, HPA077546: AB_2732351	unprognostic (1.66e-1)	unprognostic (1.03e-2)	unprognostic (8.36e-2)	unprognostic (8.72e-2)	unprognostic (1.52e-1)	unprognostic (3.76e-2)	unprognostic (1.82e-1)	unprognostic (8.20e-2)	unprognostic (1.05e-1)	unprognostic (5.93e-2)	unprognostic (6.45e-2)	unprognostic (1.07e-1)	prognostic favorable (3.12e-4)	unprognostic (7.22e-3)	unprognostic (7.89e-2)	unprognostic (4.65e-2)	prognostic unfavorable (1.88e-4)	16.8	5.1	8.3	5.2	12.5	0	3.3	4.8	10.7	15.7	9.7	7.6	0	9.6	12	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12	0.8	0	2	12.3	7.5	7.2	15	8.5	0.9	2.5	0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0	0.8	0.6	0	15.6	9.9	0	0	0	0	0	7.3	0.3	0	0	0	0	0	0	0	0.2	0	0	0	1.8	0	0	42	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	0	118	0	0	0	0	0	0	0.8	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	7.3	0	1.3	0.7	0	0	0.9	0.1	0	0	0	0	0	0.3											0	2.9	10.4	12.6	0	8.9	1.2	2.5	1.4	0	0	2	2.6	3.3	3.3	1.3	1	19.8	0	1.8	3.1	18.3	5	2.3	0	1.6	1.6	16	3.7	0.3	1.2	4	0	0	0	18.6	163.5	4.5	10.5	28.3	0.8	29.7	6.5	5.4	0.2	0.6	0	4.1	5	35.1	8	Muller glia cells
